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Abstract
The larvae of the frog Xenopus laevis is capable of regenerating lenses. In this re-
generative process, the corneal tissue is capable of forming a lens after removal of the
original lens, but the molecular mechanisms for this process is unknown. This dissertation
examines the relationship between FGF signaling and lens regeneration, exploring the
hypothesis that the FGF signaling plays a key role in triggering lens regeneration. First,
the mRNA expression levels of FGFs and FGFRs in the cornea and retina were observed,
as the key ligand from the retina travels to the cornea to interact with its receptor and
trigger lens regeneration. The described experiments found that FGF1, FGF8, and FGF9
mRNA are more expressed in the retina than the cornea, indicating that they may be
the signal for inducing lens regeneration. Three receptor mRNAs (FGFR1, FGFR2,
and FGFR3 ) were found to be expressed in the cornea. Second, the necessity of FGFR
signaling was investigated in vitro using a small molecule inhibitor (SU5402) and dominant
negative FGFR1. Both experiments demonstrated that lens regeneration is inhibited upon
FGFR signaling inhibition, indicating the necessity of FGFR signaling in lens regeneration.
Finally, the suﬃciency of various factors for lens regeneration was tested using an in vitro
cornea culture assay. FGF1 strongly induced lens formation, and FGF8 also appeared to
weakly induce lens formation, whereas FGF2 and FGF9 did not induce lens formation.
In addition, insulin and FBS also appeared to induce lens formation in cornea cultures.
Overall, this dissertation illuminates the roles that FGF signaling play in Xenopus laevis
lens regeneration. In the future, this work may guide subsequent research in treating eye
diseases.
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Chapter 1
Introduction
The vertebrate lens and cornea
The lens and cornea play important roles for vision in animals with camera eyes. In
the vertebrate eye, the lens represents a transparent ellipsoid mass suspended between
the anterior chamber just below the cornea and vitreous chamber of the eye cup. The
transparency of the lens and minimizing the amount of light scatter within the lens are
important factors for conducting light to the retina, which is essential for normal vision
(Bassnett et al., 2011; Dahm et al., 2011). The cornea, located on the outer exposed
surface of the eye, is also transparent. For terrestrial vertebrates, the cornea makes the
largest contribution to the overall refractive index of the eye, necessary for focusing light
onto the retina (reviewed in Land, 2012). The lens itself has a refractive index gradient,
required for minimizing spherical aberration and decreasing the focal length required
between the surface of the eye and the retina (Brown et al., 1999; Augusteyn, 2008).
Unlike the cornea, the lens can either change shape or position to focus an image on the
retina, but both of these tissues are required for proper focus of light onto the retina.
Lens development
The lens is derived from head ectoderm, specifically from one of the cranial placodes.
These placodal regions surround the neural plate region during late gastrulation and neu-
rulation stages in vertebrates (reviewed in Schlosser, 2010). In mammals, the lens placode
invaginates to form a lens pit, which then becomes the primitive lens vesicle that detaches
from the head epithelium (McAvoy et al., 1999; Gwon, 2006; Cvekl and Duncan, 2007).
However, in the case of Xenopus and zebrafish, a morphologically identifiable hollow lens
vesicle does not form, but the lens placode thickens and forms a lens rudiment consisting
of a solid mass of cells void of a central lumen (Mcdevitt and Brahma, 1973; Dahm et al.,
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2007). This mass of cells then develops and diﬀerentiates into the lens epithelium and lens
fibers. In both cases, the lens detaches from the head epithelium and forms a rounded
structure consisting of an anterior epithelial cell layer and a posterior elongated fiber cell
mass.
Vertebrate lens development occurs as a result of a complex suite of induction pro-
cesses. Through sequential inductive interactions, the future lens can be localized to a disc
of tissue in the region of the head ectoderm. Lens-forming competence is acquired early in
development, most prominently in gastrula stage ectoderm (stage 11-12) in Xenopus laevis
(Servetnick and Grainger, 1991). The developing tissue then gains an increasingly stronger
lens-forming bias before the approach of the optic vesicle at the neurula stage, around
stage 19 in Xenopus (Henry and Grainger, 1987, 1990; Grainger et al., 1997; Walter et al.,
2004; Jin et al., 2012). Signaling from the optic vesicle then represents the late phase of
lens development which pinpoints the site of lens development and directs the polarity of
the developing lens.
Signaling during lens development
The early phase of lens induction is characterized by the expression of a number of
transcription factors, including otx2 (Bovolenta et al., 1997; Zygar et al., 1998), pax6
(Hirsch and Harris, 1997; Li et al., 1997; Zygar et al., 1998), foxe3 (also known as Xlens1;
Kenyon et al., 1999; Blixt et al., 2000; Brownell et al., 2000), six3 (Oliver et al., 1995;
Bovolenta et al., 1998; Seo et al., 1998; Zhou et al., 2000), and sox2/sox3 (Kamachi et al.,
1995; Penzel et al., 1997; Kamachi et al., 1998; Zygar et al., 1998). Of these transcription
factors, Pax6 has been called the “master control gene” (Halder et al., 1995) for eye
development, and is necessary and suﬃcient for inducing eye development in vertebrate
embryonic tissues (Chow et al., 1999; Ashery-Padan et al., 2000; Onuma et al., 2002). As
for signaling during the early phase of lens induction, the levels of FGF8 (discussed later)
and BMPs are important for developing competence and bias (reviewed by Gunhaga, 2011;
Ogino et al., 2012). BMP7 null mice are anophthalmic or microphthalmic and the embryos
do not exhibit Pax6 expression in the presumptive lens ectoderm prior to lens placode
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formation (Dudley et al., 1995; Wawersik et al., 1999). Similarly, knocking out BMP4,
normally expressed in the optic vesicle, result in mice that do not have lens placodes
(Furuta and Hogan, 1998).
Later lens development and diﬀerentiation involves additional signaling molecules,
along with those mentioned above. During this later phase when the lens epithelium is
under the influence of the optic vesicle and retina, the lens placode is fully formed, the
lens detaches from the cornea, and the lens cells diﬀerentiate to form a mature lens in a
directed and specific manner. Transcription factors are involved in lens fiber diﬀerentia-
tion, including: prox1 (Oliver et al., 1993; Tomarev et al., 1996; Glasgow and Tomarev,
1998), mafb (Ishibashi and Yasuda, 2001; Coolen et al., 2005), sox1 (Kamachi et al., 1998;
Nishiguchi et al., 1998; Nitta et al., 2006), c-maf (Yoshida et al., 1997; Kim et al., 1999;
Ishibashi and Yasuda, 2001), and l-maf (Ogino and Yasuda, 1998; Ishibashi and Yasuda,
2001). There are a variety of signaling molecules important for the later phase of lens
development, including various FGFs (discussed later), BMPs, retinoic acid, and Wnts
(reviewed by Lovicu and McAvoy, 2005; Lovicu et al., 2011; Henry et al., 2013). Retinoic
acid signaling is necessary for the invagination of the lens placode in mice, and a precise
level of retinoid acid signaling is required for proper lens fiber morphology (Cvekl and
Wang, 2009). BMP activity in the lens equatorial region is necessary for primary lens
fiber formation in mice (Belecky-Adams et al., 2002; Faber et al., 2002) and FGF-induced
lens fiber formation in culture (Boswell et al., 2008). Although Wnt signaling is inhibited
early during lens induction (Smith et al., 2005), Wnt activity becomes necessary later for
cytoskeletal reorganization in lens fiber cell elongation (Chen et al., 2008). Other growth
factors (IGF, EGF, and PDGF) also appear to enhance lens fiber diﬀerentiation in culture
when combined with FGF (Wang et al., 2010).
The vertebrate cornea
The cornea is a thin, transparent membrane in the anterior portion of the eye. Like the
lens, the cornea is also derived from head ectoderm during early development. In mam-
mals, the early developing cornea contains an epithelial layer and a endothelial layer, and
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Figure 1.1 – Anatomy of the larval Xenopus eye
The anatomy of a Xenopus laevis larval eye is shown. At the larval stages, the cornea
epithelium and cornea endothelium form two distinct layers of tissue. In Xenopus lens
regeneration, the cornea epithelium and the pericorneal epidermis are capable of regenerating
lens tissue upon exposure to factors from the neural retina. Head ectoderm is not normally
competent to diﬀerentiate into lens. In some newts and salamanders, the iris pigmented
epithelium can transdiﬀerentiate into lens through Wolﬃan lens regeneration.
these cellular layers sandwich a stromal layer (Ozanics et al., 1976; Hay, 1980). The adult
mammalian cornea contains an epithelial layer, Bowman membrane, a thick stromal layer,
Descemet membrane and an endothelial layer (reviewed in DelMonte and Kim, 2011). In
the Xenopus larval eye, there are two morphologically separate corneal layers, similar to
the epithelial and endothelial layers of the developing mammalian cornea (Figure 1.1). The
outer cornea has two epithelial layers and a deeper fibrillar layer, and is continuous with
the head epithelium, whereas the inner cornea consists of a single layer of mesenchymal
cells and is continuous with the sclera of the eye (Freeman, 1963; Perry et al., 2013). In
later development, the outer and inner corneas fuse to form a single cornea. The adult
Xenopus cornea has a similar structure to the mammalian cornea: there is an epithelial
layer, a Bowman-like layer composed of loose collagen fibrils, a stromal layer composed of
lamellarly packed collagen fibrils, the Descemet membrane, and an endothelial layer (Hu
et al., 2013).
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Lens regeneration
Among vertebrates, the process of lens regeneration after complete lens removal is a
relatively rare phenomenon that occurs for a small subset of species. The earliest reports
of lens regeneration were for salamanders that undergo Wolﬃan regeneration, named after
one of its early scholars (Colucci, 1891; Wolﬀ, 1895, 1901). In this process, the dorsal iris
undergoes dediﬀerentiation and subsequently transdiﬀerentiates into a lens. In contrast,
the anuran Xenopus laevis has the ability to regenerate a lens from the inner basal layer of
the outer cornea (Freeman, 1963).
Wolﬃan lens regeneration
Wolﬃan regeneration occurs through transdiﬀerentiation of a portion of the dorsal
pigmented iris into lens in a process triggered after the removal of the endogenous lens
(Reyer, 1954). This method of regeneration is limited to selected species of newts and
salamanders (Henry, 2003), and diﬀers from lens development. More specifically, the origin
of the iris and lens tissues are very diﬀerent, as the embryonic dorsal iris develops from
neuronal tissue (optic cup) (Davis-Silberman and Ashery-Padan, 2008) whereas the lens
arises from placodal ectodermal tissue. From a transcriptome analysis, genes generally
involved in proliferation, cytoskeletal changes, altered gene regulation, and responsiveness
to injury were found to be enriched during lens regeneration (Sousounis et al., 2013).
Several signaling pathways appear to play a role in Wolﬃan lens regeneration (reviewed
by Grogg et al., 2006; Henry and Tsonis, 2010; Barbosa-Sabanero et al., 2012). Specific
signaling molecules observed during regeneration include FGFs (discussed on page 17),
retinoic acid (Tsonis et al., 2000), Wnts (Hayashi et al., 2006, 2008), Shh (Tsonis et al.,
2004b), and Ihh (Tsonis et al., 2004b). Inhibition of BMP signaling also appears to be
necessary for lens regeneration (Grogg et al., 2005), although BMP pathway members
were identified to be expressed in a cDNA library constructed from transdiﬀerentiating iris
mRNA (Maki et al., 2010).
5
Lens regeneration in Xenopus laevis
Unlike Wolﬃan regeneration, the lens is regenerated from the cornea epithelium in
Xenopus. There are five stages of lens regeneration in X. laevis classified by Freeman
(1963), and cell proliferation has been noted from stage 2 through stage 5 (Waggoner and
Reyer, 1975). Morphologically, this regeneration starts with the columnization of the inner
layer of corneal epithelial cells (stage 1), followed by thickening of this layer of epithelium
into a multilayered clump of cells (stage 2; Freeman, 1963; Campbell, 1965; Overton, 1965;
Waggoner, 1973). This is similar to the case in lens development where the lens arises from
the inner sensorial layer of the cornea ectoderm (Chanturishvili, 1958). The thickened
“placode” then grows into a spherical mass of cells (stage 3). The regenerating lens then
detaches from the cornea (late stage 3), starts developing primary lens fibers (stage 4),
and eventually forms a spherical lens with both primary and secondary lens fibers (stage
5; reviewed in Henry, 2003; Henry et al., 2008; Henry and Tsonis, 2010). Lens regeneration
from the cornea has been observed for X. laevis (Freeman, 1963), X. tropicalis (Henry and
Elkins, 2001), and X. borealis (Filoni et al., 2006).
Xenopus lens regeneration resembles the late phase of lens development, as lens forma-
tion from the cornea is triggered by factors that emanate from the neural retina. Similar
to development, proximity to an embryonic optic cup is suﬃcient for larval corneas to
form a lens (Cannata et al., 2008), and conversely, placement of embryonic head ectoderm
in the larval eye cup is suﬃcient for lens formation (Henry and Mittleman, 1995). Lens
regeneration from corneas occur in cases when the cornea is in a location that is accessible
to retinal factors, such as when corneas are implanted into the vitreous chamber (Reeve
and Wild, 1978; Bosco et al., 1993c; Filoni et al., 1997) or after implantation of retinal
tissue between the cornea epithelium and endothelium (Reeve and Wild, 1981). Removal
of the eyecup or neural retina, i.e. removing any retinal factors, inhibits lens regeneration
(Freeman and Overton, 1961; Freeman, 1963; Filoni et al., 1978, 1982). Also, the commu-
nication of retinal factors between the neural retina and cornea epithelium is necessary for
in vivo lens regeneration (Bosco et al., 1979, 1980; Cioni et al., 1982). Lens regeneration is
inhibited if this communication is obscured by the inner cornea (Bosco et al., 1979), the
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original lens (Bosco et al., 1980), or a disc of Millipore filter paper (Cioni et al., 1982).
Although the culture of an isolated cornea in vitro does not result in lens formation,
corneas cultured in neural retina-conditioned culture medium are able to diﬀerentiate to
lens cells (Bosco et al., 1997a). Some experiments suggest that the retinal factor(s) may
also be common to developing or regenerating limbs, as implanting a cornea into these
limbs also results in lens regeneration (Waggoner, 1973; Filoni et al., 1991; Cannata et al.,
1996). Non-corneal ectoderm can also develop competence to regenerate a lens (revealed
by later implantation into the vitreous chamber) if an eye is transplanted beneath that
ectodermal tissue early in development, suggesting a priming eﬀect of unknown factors
from the eye (Cannata et al., 2003).
Signaling in Xenopus lens regeneration
Xenopus lens regeneration involves expression of a similar array of genes as lens
development, with some diﬀerences. Through large-scale gene expression screens, a large
number of genes have been identified to be upregulated during lens regeneration (Henry
et al., 2002; Malloch et al., 2009; Day and Beck, 2011). Similar to early expression of Pax6
during Xenopus development (Hirsch and Harris, 1997; Li et al., 1997; Schaefer et al.,
1999), Pax6 can be detected as early as the first day of lens regeneration (Mizuno et al.,
1999b; Cannata et al., 2003). Other early transcription factors (otx2 and SOX3 ) have
also been detected early in lens regeneration (Schaefer et al., 1999). Prox1, a transcription
factor that appears after lens placode formation (Oliver et al., 1993; Tomarev et al.,
1996; Glasgow and Tomarev, 1998), has been detected at stage 3 of lens regeneration
or approximately 4 days after lens removal (Mizuno et al., 1999b; Schaefer et al., 1999).
The sequence of crystallin gene expression appears to be slightly diﬀerent between lens
regeneration and development. Although the ↵- and  -crystallins are expressed around
the same time as  -crystallin during development, the appearance of  -crystallin seems
to occur later during lens regeneration than the other crystallins (Brahma and Mcdevitt,
1974; Mizuno et al., 1999a; Schaefer et al., 1999).
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Lens cell regeneration in mammals
Mammals have a limited capacity for regenerating lens cells. Though not a true case of
lens regeneration, per se, early studies have shown that if the lens is removed from a rabbit
while keeping the lens capsule intact, any remaining lens epithelial cells on the capsule
may proliferate to regrow portions of the removed lens (Cocteau and Leroy-D’Etiolle,
1827; Middlemore, 1832). More recently, this phenomenon has been shown to occur in cats
(Gwon et al., 1993), rats (Lois et al., 2003), and mice (Call et al., 2004). These abnormal
forms of lens epithelial cell proliferation lead to the formation of so-called “secondary
cataracts” in human patients following cataract surgery, which must be subsequently
treated (Wormstone et al., 2009).
Fibroblast growth factor pathway
Fibroblast growth factors
One pathway known to regulate lens development is the fibroblast growth factor (FGF)
signaling pathway. The FGF proteins, historically known by their aﬃnity for heparin
(Burgess and Maciag, 1989), bind and activate fibroblast growth factor receptors (FGFRs)
(Itoh and Ornitz, 2004). The FGF family can be subdivided into seven evolutionarily
conserved subfamilies (Itoh, 2007; Itoh and Ornitz, 2011). There are 22 FGFs consisting
of FGF1-23, with FGF15/19 considered to be a single gene whose orthologs were initially
considered to be separate between mice (FGF15; McWhirter et al., 1997) and humans
(FGF19; Nishimura et al., 1999). In addition, one subfamily (FGF11-14) has functions so
distinct that it is increasingly considered to be separate from the FGF family, decreasing
the number of FGFs to 18 actual family members within six subfamilies (Olsen et al.,
2003; Goldfarb, 2005). FGFs share a core  -trefoil motif consisting of 12 anti-parallel  -
strands (Eriksson et al., 1991; Zhang et al., 1991; Zhu et al., 1991). FGFs bind to FGF
receptors (FGFRs), which are then activated through autophosphorylation, and signaling
is initiated through three main downstream pathways: the phospholipase C-gamma
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(PLC ), phosphoinositide 3-kinase (PI3K), and mitogen-activated protein kinase (MAPK)
pathways (reviewed in Dailey et al., 2005; Mason, 2007; Dorey and Amaya, 2010).
FGF subfamilies have distinct characteristics that are unique for each subfamily.
Typically, FGFs are secreted and act in a paracrine manner, binding their receptor in
conjunction with heparin sulfate. However, the FGF1 subfamily members (FGF1 and
FGF2) do not have a N-terminal signal sequence for secretion, and are secreted directly
across the plasma membrane in a golgi-independent manner (Jackson et al., 1995; Schäfer
et al., 2004; Prudovsky et al., 2008; Nickel, 2010). Another interesting subfamily is the
FGF15/19 subfamily (FGF15/19, FGF21, FGF23), with members that do not bind
heparan sulfate as readily as other FGFs and act in an endocrine manner, as opposed
to the usual paracrine action of FGFs (Harmer et al., 2004b; Goetz et al., 2007; Itoh,
2010). Instead of heparin, they require Klotho as a co-receptor to bind FGFRs (Urakawa
et al., 2006; Goetz and Mohammadi, 2013). The most distinct FGF subfamily may be the
FGF11 subfamily. Members of this subfamily (FGF11-14, also known as the fibroblast
growth factor homologous factors, FHF1-4) were identified by sequence similarity to known
FGFs, and were predicted to have an intracellular function (Smallwood et al., 1996).
FGF11 subfamily members are mainly expressed in neuronal tissues. However, this FGF11
subfamily was soon discovered to not interact with FGFRs, and have a diﬀerent mode of
action than other FGFs (Schoorlemmer and Goldfarb, 2001; Olsen et al., 2003). Instead
of binding FGFRs, these FGFs bind voltage gated sodium channels and modulate their
function in myocytes and neurons (Liu et al., 2001, 2003; Goldfarb et al., 2007; Laezza
et al., 2007).
FGF receptors
There are four FGF receptors (FGFRs) with multiple isoforms that can each interact
with diﬀerent subsets of FGFs (Table 1.1). The typical FGFR consists of three extracel-
lular immunoglobulin domains, a transmembrane domain, and two intracellular tyrosine
kinase domains (reviewed by Eswarkumar et al., 2005; Mason, 2007). Upon binding
to FGF ligands, FGFRs dimerize and undergo sequential autophosphorylation in the
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Subfamily FGF FGFR specificity
FGF1 FGF1 1b, 1c, 2b, 2c, 3b, 3c, 4
FGF2 1b, 1c, 2c, 3c, 4
FGF4 FGF4 1c, 2c, 3c, 4
FGF5 1c, 2c
FGF6 1c, 2c, 4
FGF7 FGF3 1b, 2b
FGF7 2b, 4
FGF10 1b, 2b
FGF22 1b, 2b
FGF8 FGF8 1c, 2c, 3b, 3c, 4
FGF17 1c, 2c, 3c, 4
FGF18 2c, 3c, 4
FGF9 FGF9 2c, 3b, 3c
FGF16 2c, 3c
FGF20 1c, 2c, 3b, 3c, 4
FGF11 FGF11 No FGFRs
FGF12 No FGFRs
FGF13 No FGFRs
FGF14 No FGFRs
FGF19 FGF15/19 1c, 2b, 2c, 3b, 3c, 4
FGF21 1b, 1c, 2b, 2c, 3b, 3c, 4
FGF23 1c, 2b, 3b, 3c, 4
Table 1.1 – List of known vertebrate FGF family members and corresponding
FGFR interactions
Vertebrate FGF family members are listed by subfamily, and interacting FGFR isoforms
(i.e. b, c) for each FGF are listed as determined by Ornitz et al. (1996) and Zhang et al.
(2006). Members of the intracellular FGF subfamily do not activate any known FGFR. FGFs
highlighted in bold indicate those that have been identified in X. laevis and that have been
investigated in Chapter 2.
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cytoplasmic domains, which then enable phosphorylation and activation of downstream
pathway members (Mohammadi et al., 1996; Furdui et al., 2006). Within the general
structure of FGFRs, there are a multitude of diﬀerent FGFR isoforms expressed in
vertebrates that do not have some of the domains (reviewed by Johnson and Williams,
1993; Mohammadi et al., 2005). For instance, some FGFRs have isoforms in which the
first N-terminal immunoglobulin domain is spliced out, resulting in a receptor with only
two extracellular immunoglobulin domains (Johnson et al., 1990; Mansukhani et al., 1990;
Reid et al., 1990; Miki et al., 1991; Champion-Arnaud et al., 1991). The presence of the
N-terminal immunoglobulin domain decreases FGFR activation, as this domain and its
adjacent acid box region causes FGFR autoinhibition by folding over and interacting with
the heparin-binding and FGF-binding domains (Xu et al., 1992; Wang et al., 1995; Olsen
et al., 2004; Kalinina et al., 2012).
More importantly, in the case of FGFR1, 2, and 3, the receptors each have two
major isoforms (IIIb and IIIc), distinguished by alternative splicing of exons in the third
extracellular immunoglobulin domain (Champion-Arnaud et al., 1991; Werner et al., 1992;
Avivi et al., 1993; Chellaiah et al., 1994). This spliced region is within the FGF-binding
domain, giving these FGFR isoforms aﬃnities for vastly diﬀerent groups of FGF family
members (Table 1.1; Ornitz et al., 1996; Zhang et al., 2006). The diﬀerent IIIb and IIIc
isoforms are localized to diﬀerent tissues, with IIIb isoforms expressed prominently in
epithelial cells and IIIc isoforms expressed more in mesenchymal cells (Miki et al., 1991;
Orr-Urtreger et al., 1993; Wuechner et al., 1996). There is also an additional FGFR-
like protein (FGFRL1, or alternatively, FGFR5) that has sequence similarity with the
extracellular region of FGFRs, but is lacking the intracellular tyrosine kinase domains
(Wiedemann and Trueb, 2000; Kim et al., 2001; Sleeman et al., 2001). Like FGFRs, it
is capable of binding many FGFs, and its role appears to be inhibition of FGF signaling,
possibly as a decoy receptor or in a dominant negative manner through dimerization with
FGFRs (reviewed by Trueb, 2011).
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Heparan sulfate facilitates FGF-FGFR binding
Heparan sulfate is an important factor for FGF-FGFR binding (Yayon et al., 1991;
Rapraeger et al., 1991). Heparan sulfate consists of a chain of repeating disaccharide units
(uronic acid and a glucosamine derivative), with varying amounts of sulfation on each unit
(Esko and Selleck, 2002). For FGFs, all of the subfamilies with a paracrine mode of action
have a high aﬃnity for heparin (Asada et al., 2009). An exception are the members of the
FGF15/19 subfamily that have little to no aﬃnity for heparin, and act in an endocrine
manner. Within the paracrine FGF subfamilies, each subfamily shares a slightly diﬀerent
heparin binding site, leading to diﬀering aﬃnities between FGF subfamilies for various
heparan sulfate molecular structures (Xu et al., 2012). Furthermore, all of the FGFRs have
extracellular heparin binding sites (Kan et al., 1993; Hecht et al., 1995; LaRochelle et al.,
1999; Loo et al., 2001). Structurally, a 2:2:2 arrangement of FGF, FGFR, and heparan
sulfate binding can lead to FGFR activation (Schlessinger et al., 2000; Mohammadi et al.,
2005; Goetz and Mohammadi, 2013), or possibly a 2:2:1 arrangement in which only one
heparan sulfate is present in the complex (Pellegrini et al., 2000; Harmer et al., 2004a;
Harmer, 2007).
FGF downstream pathways
There are three main downstream pathways for FGF signaling. Of these, the MAPK
and PI3K pathways share a common upstream mechanism involving binding of FGFR with
FRS2↵, which then binds Shp2 and Grb2 (Hadari et al., 1998; Ong et al., 2001). The third
downstream pathway is the PLC /calcium pathway (Carpenter and Ji, 1999). To activate
the MAPK pathway, Grb2 binds and activates SOS to activate Ras, eventually leading to
a series of downstream phosphorylation events that promote cell proliferation (Kouhara
et al., 1997; Hadari et al., 2001). The MAPK pathway is inhibited by Sef, a protein
expressed upon FGF signaling activation (Fürthauer et al., 2002; Tsang et al., 2002;
Ron et al., 2008). Sprouty is also a potent inhibitor of the MAPK downstream pathway,
potentially through an interaction with Grb2 (Cabrita and Christofori, 2008). For the
PI3K pathway, Grb2 binds Gab1 with then recruits PI3K and activates downstream Akt
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signaling for cell survival (Ong et al., 2001; Lamothe et al., 2004). PLC  is activated by
FGFR at a site diﬀerent from FRS2↵ (Mohammadi et al., 1991; Peters et al., 1992), and
the associated pathway leads to intracellular signaling via PKC activation and calcium
release (Carpenter and Ji, 1999).
Role of FGF pathway in lens development
In vertebrates, the FGF pathway plays important roles in embryonic lens development
(reviewed in Donner et al., 2006; Robinson, 2006; Gunhaga, 2011). Historically, FGF
activity on lens cells was identified early, as FGFs were formerly called “eye-derived growth
factors” (Barritault et al., 1981; Arruti et al., 1985) before they were recognized to be iden-
tical to FGFs from other tissues (Baird et al., 1985b; Courty et al., 1985; Schreiber et al.,
1985). FGF pathways are active both in the early and late phases of lens development,
encompassing early placode formation through lens fiber diﬀerentiation (Robinson, 2006;
Gunhaga, 2011).
FGF function in lens development
In the early phase of lens development, lens cell fate is determined within a subset of
the cranial placodes including the presumptive lens ectoderm. FGF expression, in combi-
nation with BMP and Wnt antagonists, is necessary for cranial placode formation (Litsiou
et al., 2005). In early rostral tissues, FGF8 expression is required for determination of
placodal fates (Sjödal et al., 2007). More specifically, inhibition of FGF signaling in chick
embryos at gastrulation caused epidermal cell formation instead of placodal formation, and
placodal cell generation was rescued by FGF8 application. In the mouse model, chemical
inhibition of FGFR signaling using SU9597 inhibited Pax6 expression and led to the later
formation of a smaller lens pit (Faber et al., 2001). However, an excess of FGF pathway
activation in a cranial placode leads to a non-lens fate (Bailey et al., 2006). Upon placode
formation, the mouse lens placode has high levels of FGFR1 and FGFR2 expression, as
determined by microarray and RT-PCR analyses (Garcia et al., 2011). Dominant negative
inhibition of FGFR signaling by conditionally expressing truncated FGFR1 (specific to the
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lens via the pax6 promoter) generated transgenic mice with a smaller lens placode, and
later developing smaller lenses throughout embryogenesis (Faber et al., 2001). Similarly, in
a mouse conditional knockout of FGFR2 in a lens placode specific manner (using a pax6
promoter), there were defects in eyelid formation, small lenses, and increased apoptosis
among lens fiber cells (Garcia et al., 2005). If both FGFR1 and FGFR2 were conditionally
knocked out, there was increased apoptosis within the lens placode and a thinner lens
placode was present. These mouse embryos typically did not have detectable lens tissue
at birth (Garcia et al., 2011).
During later eye development, an FGF concentration gradient between the vitreous
and aqueous humors plays an important role in determining lens polarity. There is a
greater concentration of FGF in the vitreous humor than the aqueous humor (Caruelle
et al., 1989; Schulz et al., 1993) aﬀecting the FGF concentrations in the lens capsule
surrounding the lens (de Iongh and McAvoy, 1992; Lovicu and McAvoy, 1993), helping
determine lens polarity (Chamberlain and McAvoy, 1997). More specifically, increasing
FGF concentrations induce cultured rat lens epithelial cells to proliferate (150 pg/mL),
migrate (3 ng/mL), and then elongate into lens fiber cells (40 ng/mL) expressing ↵- and
 -crystallin (Chamberlain and McAvoy, 1989; Lovicu and McAvoy, 1989; McAvoy and
Chamberlain, 1989). Similarly, chick lens epithelial cultures also diﬀerentiate into lens fiber
cells upon FGF stimulation (Le and Musil, 2001) although not as rapidly as treatment
with vitreous humor (Huang et al., 2003), and FGF8 application in the developing chick
embryo results in increased lens fiber diﬀerentiation (Vogel-Höpker et al., 2000). Some
FGF9 knockout mice have delayed lens fiber diﬀerentiation (Zhao et al., 2001). Lens-
specific overexpression of FGF3, 4, 7, 8, or 9 or a secreted FGF1 in the mouse using an
↵A-crystallin promoter resulted in premature diﬀerentiation of lens epithelial cells into
lens fiber cells (Robinson et al., 1995b; Lovicu and Overbeek, 1998; Robinson et al., 1998;
Govindarajan and Overbeek, 2001). These experiments emphasize the importance of
the precise FGF concentration gradient in lens development. The FGF gradient is also
important for lens fiber cell orientation, as lens-specific overexpression of FGFs in mice
disrupts lens organization (Stolen et al., 1997; Lovicu and Overbeek, 1998; Robinson
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et al., 1998). In an interesting study, Yang et al. (2010) devised a protocol to induce
diﬀerentiation of human embryonic stem cells into lens cells and found that FGF signaling
was essential in the later stages of diﬀerentiation. More specifically, the later application
of FGF2 (day 6 to day 35) was part of the optimal treatment to form lentoids in culture
(Yang et al., 2010). This FGF requirement in stem cell diﬀerentiation appears to span the
period of forming lens progenitor cells through early lens fiber diﬀerentiation. In a striking
illustration of FGF necessity, a FGF9 mutation (Y162C) in the mouse model gives rise to
a lens-specific phenotype in an otherwise normally developing mouse, consisting of smaller
lenses and reduced vision due to defective lens fiber diﬀerentiation (Puk et al., 2011).
FGFR function in lens development
As for the receptors, an in situ study noted the presence of murine FGFR3 in the
embryonic E14.5 lens but not any other FGFRs (Yaylaoglu et al., 2005). Early transgen-
esis studies in mice indicated that inhibiting FGFR function in general using a truncated
dominant negative FGFR1 (capable of heterodimerizing and inhibiting multiple FGFRs;
Ueno et al., 1992) disrupted lens development (Chow et al., 1995; Robinson et al., 1995a).
Disruption of FGFR3 function in transgenic mice specific to the lens region also leads
to a lens with a larger amount of epithelial cells and fewer fiber cells (Govindarajan and
Overbeek, 2001). This was accomplished by expressing a soluble extracellular portion of
FGFR3 with an ↵A-crystallin promoter. Interestingly, the equivalent transgenic mouse
with FGFR1 disruption did not exhibit these abnormalities, with lenses that resembled
those of nontransgenic mice. A similar experiment using a Cre/flox system to conditionally
delete FGFR1 expression in lenses also did not result in lens defects, nor did using null
FGFR1 embryonic stem cells in chimeric mice (Zhao et al., 2006). In addition, the double
mutant with conditional deletions of both FGFR1 and FGFR2 using an ↵-crystallin
promoter also was developmentally normal (Zhao et al., 2008). On the other hand, the
triple mutant mouse with conditional deletion of FGFR1, 2, and 3 in lens cells had a
severe lens defect with decreased lens fiber elongation and no  -crystallin expression (Zhao
et al., 2008; Newitt et al., 2010). Only a single allele of FGFR2 or FGFR3 expressed in the
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lens was required to rescue the FGFR deficient lens back to a normally developing lens,
suggesting redundancy in function between FGFRs (Zhao et al., 2008). These deletion
studies suggest that FGFR function is necessary, but no single FGFR plays a defining
role in mouse lens development. Supporting the notion of FGFR necessity, deletion of
Ndst1, an enzyme required for heparan sulfate synthesis, causes diminished FGF-FGFR
binding and also gives rise to lens defects (Pan et al., 2006; Qu et al., 2011). In particular,
Qu et al. (2011) found that FGF3-FGFR3b binding on lens cell surfaces was almost
completely inhibited (as opposed to somewhat weaker FGF3-FGFR1b binding and intact
FGF3-FGFR2b binding) after Ndst1 deletion. This suggests that FGFR3 function plays an
important role in lens fiber diﬀerentiation, possibly in conjunction with the FGF gradient
(Govindarajan and Overbeek, 2001).
FGF and FGFR expression in Xenopus lens development
Members of the FGF pathway have been identified to be expressed in Xenopus lens
and cornea tissues. FGF1, FGF3, FGF13, FGF14, and FGF20 were found in Xenopus
eye tissues in an in situ study of embryos across a variety of stages (Lea et al., 2009).
Furthermore, all four FGFRs were found to be expressed in various Xenopus eye tissues.
FGFR3 was especially found to be expressed in the lens (Lea et al., 2009), similar to the
case in mouse (Peters et al., 1993), newt (Shi et al., 1994), rat (de Iongh et al., 1997) and
chick (Walshe and Mason, 2000) lenses. FGFR2 was found in the cornea of the Xenopus
stage 35 and stage 40 eyes, after the formation of a lens (Lea et al., 2009).
Sef/Spry in lens development
Sef and Spry have also been observed to have a role in lens development. Spry1 mRNA
is expressed in the embryonic rat lens vesicle and later in the developing lens epithelium,
and Spry2 is expressed ubiquitously in all embryonic developing rat lens tissues and then
lost in the most mature lens fiber cells postnatally (Boros et al., 2006). Spry2 expression
was confirmed by immunofluorescence, with expression most prominent in the lens
epithelium and early lens fiber cells. A mouse conditional deletion of Spry1 or Spry2 in
the lens using the Pax6 promoter resulted in a failure of the lens vesicle to detach from the
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cornea, and premature lens fiber diﬀerentiation (Kuracha et al., 2011). This phenotype was
present for both individual Spry1 and Spry2 deletions and also for the double-null (Spry1
and Spry2 ) lenses. A preliminary survey of Spred2 expression in mice included slightly
positive expression in the developing lens vesicle and later lens (Tuduce et al., 2010). As
for Sef, similar to the Spry1 expression pattern, Boros et al. (2006) found that Sef protein
is strongly expressed in the lens epithelium in a variety of species (mouse, rat, chicken,
cow, and human). Overexpression of Sef in the mouse lens led to inhibition of lens fiber
cell elongation, similar to the case in FGFR null mice (Newitt et al., 2010).
Role of FGF pathway in lens regeneration
FGF pathway in Wolﬃan lens regeneration
Wolﬃan regeneration studies in the newt have shown that FGF and FGFR family
members are expressed in the dorsal iris as it is transdiﬀerentiating into a lens. FGF1
and FGF2 expression are both correlated with lens regeneration. An in situ study noted
that FGF1 was expressed in the dediﬀerentiating dorsal iris and regenerating lens after
lens removal (Del Rio-Tsonis et al., 1997). FGF2 was also identified by RT-PCR to be
upregulated in both the ventral and dorsal iris after lens removal (Hayashi et al., 2004).
in a recent transcriptome analysis comparing expression between ventral and dorsal iris
after lentectomy, FGF10 expression was enriched in the dorsal iris relative to the ventral
iris both 4- and 8- days post lentectomy and was confirmed by qRT-PCR (Sousounis
et al., 2013). FGFR1, 2, and 3 are expressed in the iris tissues during lens regeneration.
In contrast, the normal newt iris expresses FGFR2 and FGFR3 mRNA but not FGFR1
(Del Rio-Tsonis et al., 1997, 1998). FGFR1 protein is expressed in the dorsal lens-forming
iris and the lens epithelium of the regenerated lens, but not in the ventral iris, although
a detectable amount of FGFR1 mRNA by in situ is present in the ventral iris (Del Rio-
Tsonis et al., 1998). FGFR2 expression is seen in both the ventral iris and dorsal iris
during regeneration, and was also observed in the regenerating lens (Del Rio-Tsonis et al.,
1997). FGFR3 is also expressed more in the dorsal iris than the ventral iris, especially 9
days after lens removal (McDevitt et al., 1997).
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FGF pathway activation has been shown to be necessary for Wolﬃan lens regeneration.
In a study that applied SU5402, a small molecule inhibitor of FGFR tyrosine kinase activ-
ity, lens regeneration was inhibited, suggesting that FGFR activation is necessary for lens
regeneration (Del Rio-Tsonis et al., 1998). In a more recent study, Hayashi et al. (2004)
used a daily injection of a soluble competitive recombinant FGFR2 IIIc (FGFR2/Fc) into
the eye to study the eﬀects of FGFR inhibition. FGFR2/Fc injection resulted in inhibition
of lens regeneration, whereas the injection of a similar soluble recombinant FGFR2 (IIIb)
did not inhibit lens regeneration. Thus, the specific FGFR IIIc isoform may be required
for lens regeneration (Hayashi et al., 2004). In addition, like development, FGF pathway
activation plays a role in lens structure and lens fiber diﬀerentiation. Application of
exogenous recombinant FGF1 or FGF4 during the lens regeneration process perturbs the
structure of the regenerated lens, and can result in multiple lens formation (Del Rio-Tsonis
et al., 1997; Yang et al., 2005). These experiments demonstrate the the precise gradient of
FGF is necessary for proper lens structure in the later stages of lens regeneration.
FGF pathway activation by specific FGF ligands appears to be suﬃcient to induce
Wolﬃan lens regeneration in newt tissues. Hayashi et al. (2002) examined the eﬀect of
adding FGF2, FGF4, FGF8, FGF10, EGF, IGF1, and VEGF to cultured newt dorsal iris
epithelial cells. Of these ligands, FGF2 and FGF4 were suﬃcient to induce in vitro lens
development in these cultures, in a similar manner as Wolﬃan lens regeneration in vivo.
Furthermore, a FGFR inhibitor (SU5402) was able to inhibit this eﬀect, strengthening
the argument that FGF2 and FGF4 may be key ligands for specific FGF receptors in this
transdiﬀerentiation process (Hayashi et al., 2002). Interestingly, an earlier in vitro culture
study of embryonic chick retinal pigmented epithelial cells also noted that FGF2 addition
to the culture medium resulted in formation of lentoid bodies, mimicking Wolﬃan lens
regeneration (Hyuga et al., 1993). In a later in vivo study, Hayashi et al. (2004) examined
the eﬀect of injecting FGF1, 2, 4, 7, 8, 9, and 10 into the anterior or posterior chamber of
the eye without lens removal, as well as EGF, IGF, and VEGF. Of these growth factors,
only FGF2 was suﬃcient to induce the formation of a second lens from the dorsal iris tis-
sue. This suggests that FGF2 signaling is a key factor for Wolﬃan lens formation. Taken
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together, these Wolﬃan regeneration studies suggest that FGF2 activating FGFR2 IIIc,
leading to activation of downstream pathways, is important for transdiﬀerentiation from
iris to lens. The nature of these activated downstream pathways is not fully understood.
FGF pathway in Xenopus lens regeneration
Expression of members of the FGF pathway has been observed in the regenerating
Xenopus cornea and retina. Day and Beck (2011) performed a microarray analysis that
compared transcript expression between regenerating Xenopus corneas, lenses, and sham
operated corneas (an operation where the cornea endothelium and lens were allowed to
remain intact, thus not inducing regeneration). In this analysis, FGF8b was identified
to be upregulated in regenerating corneas. Similarly, in our lab, a subtracted cDNA
library was analyzed to detect diﬀerences in gene expression between control corneas
and corneas undergoing lens regeneration (Henry et al., 2002). In an analysis of this
data, FGFR3 was identified to be up-regulated in regenerating corneas (Malloch et al.,
2009). This subtracted library also identified other downstream members of the FGF
pathways. Specifically, mek2 (MAPK pathway), grb2 (upstream of the MAPK and PI3K
pathways), and spry2 (negative regulator of FGFRs) were identified to be upregulated
in the regenerating cornea (Malloch et al., 2009). Using immunohistochemistry, Arresta
et al. (2005) correlated FGFR2 (also known as Bek) protein expression with regions of
ectoderm tissue competent to form a lens (i.e. the cornea and pericorneal ectoderm).
FGFR2 was not present in flank epidermis, which is not competent to form a lens at the
stages examined (Arresta et al., 2005). The authors also found that autotransplantation
of an eye underneath head epidermal tissue, in regions that are not normally competent to
regenerate a lens, increases the competence of that epidermal tissue to regenerate a lens,
as shown previously by Cannata et al. (2003). They demonstrated that this operation
leads to an increase in FGFR2 expression in treated head epidermal tissue, relative to
normal head epidermis (Arresta et al., 2005). There is some evidence for the suﬃciency
of FGF pathway activation in cornea lens regeneration: the application of a relatively
high concentration of FGF1 (500 ng/mL) was found to be suﬃcient for lens cell formation
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(though not complete lenses) in cultured Xenopus corneas (Bosco et al., 1994, 1997b).
This dissertation will expand upon the knowledge of the correlation between the FGF
pathway and Xenopus lens regeneration in Chapters 2 and 3.
Role of insulin and IGF in lens development and regeneration
Insulin and IGF may play important roles in lens development. Both insulin receptors
and IGF receptors are present in various vertebrate lens epithelial and fiber cells (Hol-
lenberg, 1975; Bassas et al., 1987; Bassnett and Beebe, 1990; Sinha et al., 1990; Jacobs
et al., 1992; Ibaraki et al., 1996; Naeser, 1997). IGF may play a necessary role in chick
lens fiber diﬀerentiation, as lens fiber diﬀerentiation following addition of vitreous humor
in chick lens epithelial cultures was attenuated by treatment with IGF1 antibody (Beebe
et al., 1987). As for suﬃciency, addition of insulin or IGF both induce cultured chick
lens epithelial cells to proliferate and initiate fiber diﬀerentiation, increasing  -crystallin
expression levels (Milstone and Piatigorsky, 1977; Le and Musil, 2001). Similarly, addition
of insulin or IGF to rabbit lens epithelial cell cultures induced cell proliferation in a dose-
dependent manner (Reddan et al., 1975; Reddan and Wilson-Dziedzic, 1983). On the other
hand, in the mouse system, overexpression of IGF1 in lens cells did not appear to induce
early lens fiber diﬀerentiation (Shirke et al., 2001). Insulin or IGF treatment in the rat lens
epithelial explant system has only a modest eﬀect on increasing lens fiber diﬀerentiation,
as measured by crystallin expression, but the combination of FGF and insulin or IGF1
greatly enhanced crystallin expression relative to adding each factor alone (Chamberlain
et al., 1991; Richardson et al., 1993; Civil et al., 2000). Transgenic overexpression of IGF1
(Shirke et al., 2001) or the receptors for insulin or IGF (Xie et al., 2007) in the mouse
lens expands the transitional zone of the lens epithelium and shifts the location of the
germinative zone resulting in defective lens morphology, suggesting that these factors help
specify the location of the germinative (equatorial) zone during development.
There is conflicting evidence on the correlation between Wolﬃan lens regeneration
and insulin or IGF. There is a single early abstract by Williams and McGlinn (1979)
claiming that insulin supplementation in newt iris cultures induced lens fiber formation.
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However, another study found that although insulin in newt iris cultures may enhance
depigmentation, insulin treatment did not lead to lens formation (Connelly, 1980). As for
IGFs, cultured newt irido-corneal complexes in vitro responded to IGF1 treatment with
lens fiber formation (Connelly and Green, 1987). On the other hand, addition of IGF1 to
cultured newt iris cell reaggregates did not promote lens formation (Hayashi et al., 2002).
IGF1 injection into the anterior chamber of the eye in the newt also did not induce lens
regeneration (Hayashi et al., 2004). To date, no studies have investigated the role of IGF
or insulin in Xenopus lens regeneration. This dissertation will examine the correlation
between insulin and Xenopus lens regeneration in Chapter 3.
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Chapter 2
FGF signaling is Required for Lens Regeneration in
Xenopus laevis
Introduction
The fibroblast growth factors (FGFs), formerly known as “heparin-binding growth
factors,” are a family of growth factors with high aﬃnity for heparin sulfate proteoglycans
(reviewed in Ornitz and Itoh, 2001). In mammalian systems, there are a total of 22 FGFs,
numbered FGF1-23, as FGF15/19 represents a single FGF initially discovered in diﬀerent
species (mouse FGF15 and human FGF19; Ornitz and Itoh, 2001; Robinson, 2006). These
FGFs have been divided into seven subfamilies, each classified by sequence homology (Itoh
and Ornitz, 2004; Itoh, 2007; see Table 1.1). Among the members of the FGF family,
significant diﬀerences among FGFs concerning localization and function have been found
between various tissues (Xu et al., 1999; Ford-Perriss et al., 2001; Bottcher and Niehrs,
2005; Dailey et al., 2005; Thisse and Thisse, 2005; Robinson, 2006; Itoh, 2007; Lea et al.,
2009). However, the members of specific FGF subfamilies generally have common FGFR
receptor specificities, suggesting similar downstream eﬀects may be elicited by members
of each subfamily (Ornitz et al., 1996; Zhang et al., 2006). There are a total of four FGF
receptors (FGFRs), and each has multiple isoforms. The most commonly made distinction
in FGFR isoforms are the IIIb and IIIc isoforms, diﬀering by alternative splicing of a
pair of exons, and possessing diﬀerent FGF aﬃnities (Groth and Lardelli, 2002). Known
FGF/FGFR interactions are summarized in Table 1.1.
It is well established that some vertebrates are able to regenerate parts of the eye
including the lens (Henry, 2003; Tsonis and Del Rio-Tsonis, 2004; Filoni, 2008; Henry
et al., 2008; Henry and Tsonis, 2010). Lens regeneration is restricted among vertebrates,
generally limited to some urodeles and anurans of the genus Xenopus (Henry, 2003; Tsonis
This chapter previously published in: Fukui, L. and Henry, J. J. 2011. Biol. Bull. 221:137-145. Reprinted
with permission from the Marine Biological Laboratory, Woods Hole, MA.
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et al., 2004a; Henry et al., 2008; Henry and Tsonis, 2010). The latter include X. laevis
(Freeman, 1963), X. tropicalis (Henry and Elkins, 2001), and X. borealis (Filoni et al.,
2006). In Xenopus lens regeneration, the outer cornea epithelium forms a thickening and
subsequently a lens vesicle that develops into a mature lens (Freeman, 1963). Thus, in
Xenopus, both the embryonic lens and the regenerated lens originate from head ectodermal
tissues. There has been some evidence correlating FGF pathway function with Xenopus
lens regeneration. In one study, it was shown that the addition of FGF1 protein (formerly
referred to as “aFGF” or “acidic FGF”) to isolated cultured corneas would trigger lens cell
diﬀerentiation (Bosco et al., 1997b). Specifically, Bosco et al. (1997b) showed that the ad-
dition of FGF1 enabled cultured outer corneas to undergo transdiﬀerentiation into lentoids
containing lens fibers, whereas these cultures in media alone do not transdiﬀerentiate. In
addition, a later study demonstrated a correlation between FGFR2 protein expression
and lens regeneration competent ectoderm (Arresta et al., 2005). In this study, Arresta
et al. (2005) established that only thosse ectodermal tissues known to be competent to
transdiﬀerentiate into lenses were labeled by an antibody specific to FGFR2 IIIc protein,
also known as the bek isoform of FGFR2, suggesting that FGFR2 may play a role in
Xenopus lens regeneration.
Currently, we do not know exactly which FGFs and FGFRs are expressed in Xenopus
larval eye tissues, and the requirement of FGFR signaling has not been shown in the
context of cornea-lens transdiﬀerentiation in the larval eye. To examine these questions,
we have characterized the expression of FGFs and FGFRs during lens regeneration, and
further, using a pharmacological inhibitor of FGFRs (SU5402), our experiments suggest
the necessity of FGFR function in lens regeneration in X. laevis.
Results
FGFs are expressed in cornea and retinal tissues
RT-PCR experiments were performed to assess the expression of FGFs in the cornea
epithelium and neural retina during various time points prior to and during lens regener-
ation. mRNA expression within cornea and retinal tissues was evaluated in both control
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Figure 2.1 – RT-PCR expression of FGFs in eye tissues
Expression of FGFs as determined by RT-PCR assays. Total RNA was collected from
corneas and retinas of both non-regenerating control and lens-regenerating larvae.
Regenerating corneas and retinas were collected at four timepoints (1, 3, 5, and 7 days after
lens removal). Note that the bands for FGF1, FGF8, and FGF9 are uniformly less intense
in the cornea when compared to the retina, as determined from replicate RT-PCR reactions.
0d denotes non-regenerating control eye tissues; + denotes positive control cDNA derived
from mRNA of whole embryos (st. 37-38); - denotes the negative control without addition of
template cDNA.
non-regenerating and regenerating eye tissues during four timepoints (1, 3, 5, and 7
days) following lens removal. The presence of mRNA was assessed for the presence of all
Xenopus laevis FGF sequences included in the NCBI database (i.e. FGF1, 2, 3, 4, 7, 8,
10, 12, 13, and 20 ). In addition, RT-PCR primers were designed from available genomic
Xenopus tropicalis FGF sequences in the JGI genome database for those not available
in the NCBI database. Primers were successfully designed for six additional FGFs in X.
laevis (FGF5, 9, 11, 14, 15/19, and 16 ; Table 5; amplicon GenBank accession numbers are
JF433082, JF433083, JF433084, JF433085, JF433086, and JF433087 respectively). PCR
products were verified by sequence analysis. Eleven FGFs (FGF1, 2, 5, 7, 8, 9, 10, 11,
12, 13, 14, and 16 ; see Fig. 2.1) were detected in both control cornea tissues and corneas
undergoing the process of lens regeneration. Twelve FGFs (FGF1, 2, 5, 7, 8, 9, 10, 11, 12,
13, 14, and 16 ; see Fig. 2.1) were detected in retinal tissues throughout these timepoints.
Though these assays are not quantitative, some potential diﬀerences were observed in the
level of the amplified PCR products for certain FGFs and at various time points (Fig. 2.1).
Of interest, the expression levels of FGF1, FGF8, and FGF9 mRNA in the cornea were
consistently lower than the corresponding levels in the retina.
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Figure 2.2 – RT-PCR expression of FGFRs in eye tissues
Expression of FGFRs as determined by RT-PCR assays. Total RNA was collected
from corneas and retinas of both non-regenerating control and lens-regenerating larvae.
Regenerating corneas and retinas were collected at four timepoints (1, 3, 5, and 7 days after
lens removal). 0d denotes non-regenerating control eye tissues; + denotes positive control
cDNA derived from mRNA of whole embryos (st. 37-38); - denotes the negative control
without addition of template cDNA.
FGFRs are expressed in cornea and retinal tissues
Similarly, RT-PCR experiments were performed to characterize the expression of
FGFRs in the cornea and retina during lens regeneration. As shown in Figure 2.2, only
FGFR1, 2, and 3 were expressed in the cornea throughout the period of regeneration
examined in this study. In contrast, all four FGFRs were detectable in the retina, though
more prominent levels of PCR product were consistently observed for FGFR1 and 4.
SU5402 application inhibits lens regeneration
Increasing dosages of SU5402 (2µM, 5µM, 10µM, and 25µM), a FGFR inhibitor, were
tested for their ability to inhibit lens regeneration. Lenses were identified in sectioned eye
cultures via anti-lens antibody staining (Fig. 2.3). Under control conditions (0.25% DMSO
in modified L-15 medium), 82% of cultured eyes regenerated a lens (23 out of 28 cases;
Fig. 2.3A-B, 2.4). On the other hand, application of SU5402 resulted in a dose-dependent
inhibition of lens regeneration (Fig. 2.3C-L, 2.4). Though there was no inhibition of lens
regeneration with 2µM SU5402 (81% regeneration; 13 out of 16 cases examined; p = 0.62),
there was almost no regeneration at the higher concentrations tested (10µM and 25µM
SU5402). Furthermore, individual cases of lens regeneration at the higher concentrations
of SU5402 were small and represented only a preliminary stage of lens regeneration (stage
2, as described in Freeman 1963), in which the developing lens appears only as a thickening
of the cornea epithelium (data not shown). The lens regeneration rate was halved at 5µM
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SU5402 (38% regeneration; 6 out of 16 cases), representing a significant decrease in the
lens regeneration rate relative to the control cases (p = 0.0038). There was almost no
regeneration upon application of 10µM SU5402 (5.9% regeneration; 1 out of 17 cases; p =
4.5e-7) and 25µM SU5402 (2.5% regeneration; 1 out of 40 cases; p = 2.6e-12). From this
data, the IC50 for lens regeneration can be determined to be approximately 5µM SU5402.
The cultured eye tissues otherwise all appeared to be healthy and of normal morphology at
all doses tested (see Fig. 2.3).
Discussion
Experimental evidence shows that critical retinal factors trigger Xenopus cornea-
lens transdiﬀerentiation or “lens regeneration”. Through the removal of various eye
tissues after lentectomy, Filoni et al. (1982) found that the presence of the neural retina
was key to inducing lens regeneration during larval stages. In X. laevis, although lens
regeneration ability declines as the tadpole ages (Freeman, 1963), cornea epithelia from
later stages including adult frogs inserted into the vitreous chamber are still capable of
transdiﬀerentiating into lenses in culture (Filoni et al., 1997). Bosco et al. (1993c) showed
that the presence of neural retina was suﬃcient to induce lens regeneration in cultured
corneas. Further, Bosco et al. (1997a) showed that corneas transdiﬀerentiated into lens
after exposure to centrifuged, filtered, retina-conditioned culture medium, thus indicating
that some diﬀusible factor was responsible for inducing lens regeneration. From this
evidence, one can hypothesize that a retinal signaling ligand is responsible for inducing
lens regeneration, though this has yet to be identified.
As the retina represents the source of key signaling factors required to support lens
regeneration, it is possible that one or more of the FGFs detected in the present study
could play a role in this process. Normally, the cornea is isolated from the signaling factors
provided by the retina via the presence of the lens and the inner cornea endothelium
(Freeman, 1963). This ensures that supernumerary lenses are not normally formed in the
larval eye (Reeve and Wild, 1978; Bosco et al., 1979; Filoni et al., 1980). Although we
are describing expression at the level of transcription, one could argue that key signals
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Figure 2.3 – Sectioned eyes after SU5402 treatment in culture
Development of control and SU5402 treated in vitro eye cultures. SU5402 inhibits FGFR
function by competitively binding to the FGFR kinase domain. The left column shows
sections of representative eyes imaged using diﬀerential interference contrast. The right
column shows each corresponding fluorescent image illustrating a-lens antibody staining.
SU5402 concentrations: (A-B) 0µM control; (C-D) 2µM; (E-F) 5µM; (G-J) 10µM; (K-L)
25µM. The single case of lens regeneration with 10µM SU5402 is shown in G-H. The typical
results of non-regenerating cases are shown for 10µM SU5402 (H-I) and 25µM SU5402 (K-L).
Arrows point to regenerated lenses; scale bar equals 200µm.
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Figure 2.4 – Lens regeneration rates upon application of SU5402
Results of in in vitro eye culture experiments treated with SU5402 to inhibit FGFR function.
As shown here, the IC50 for inhibiting lens regeneration is close to 5µM SU5402. Numbers
of regenerated lenses and eyes examined are located above each bar; y-axis indicates lens
regeneration rate; error bars denote Wilson score intervals in which Z=1.
involved in lens regeneration should be expressed only by the retinal tissue and not be
expressed in the cornea. Likewise, as the receptor for presumptive FGF signaling, the
associated FGFRs should be expressed in the cornea during lens regeneration.
Though the RT-PCR analyses reported here are not quantitative, some potential
diﬀerences in expression between retina and cornea may exist for FGF1, 8, 9, 11, and 14
based on the rather dramatic diﬀerences in the intensity of the PCR products detected
(Fig. 2.1). Of these, FGF11 and FGF14 are members of the intracellular FGF subfamily,
formerly known as the FGF11 subfamily or the FGF homologous factors, which are
expressed in neuronal tissues and do not interact with known FGFRs (Table 1.1; Olsen
et al., 2003; Goldfarb, 2005; Itoh and Ornitz, 2008). Hence, FGF1, FGF8, and FGF9 are
plausible candidate FGFs that could represent the key retinal signal(s) that trigger lens
regeneration. Other FGFs (FGF2, 5, 7, 10, 12, 13, and 16 ) were also expressed by retinal
tissues and could represent key signals involved in lens regeneration. Of course, this study
describes expression at the level of transcription, and it will be important to examine
expression at the level of translation in future studies.
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From compiling studies in various vertebrates, Robinson (2006) noted that certain
members of all seven subfamilies of the FGFs and all four FGFRs (1-4) have been ob-
served in the eye during development or in the adults of various vertebrates. In a recent X.
tropicalis study, Lea et al. (2009) showed that FGF1, FGF3, FGF13, FGF14, and FGF20
are expressed during embryonic eye development. Here we have found additional FGFs
(FGF2, 5, 7, 8, 9, 10, 11, 12, and 16 ) that are expressed in the eye during the later larval
stage of X. laevis (i.e., stage 48-51) and have not been able to detect FGF3 and FGF20.
Furthermore, during embryonic lens development in X. tropicalis, FGFR3 is expressed in
the developing lens, FGFR2 is prominently expressed in corneal epithelium, and FGFR1
and FGFR4 are expressed in “cells surrounding the lens” in early tadpoles (Lea et al.,
2009). This is similar to our finding that FGFR1 and FGFR4 are prominently expressed
in the larval retina, whereas FGFR1, FGFR2, and FGFR3 are expressed in the cornea.
As for lens regeneration, previous research using X. laevis corneal explant cultures
has shown that addition of FGF1 protein, previously known as acidic or aFGF, to cornea
explants induced the transdiﬀerentiation of these cells into lens cells (Bosco et al., 1997b).
In these experiments, the authors established this using in vitro cultured outer cornea
epithelium. The corneas transdiﬀerentiated only when FGF1 was added to the serum
supplemented L-15 media. Our results agree with the notion that FGF1 may be a signal-
ing ligand for inducing cornea-lens transdiﬀerentiation. In the newt, as opposed to other
FGFs (e.g., 1, 4, and 7-10) and various growth factors (i.e., EGF, IGF, and VEGF), FGF2
has the unique ability to trigger the generation of a new lens after injection into the eye
chamber (Hayashi et al., 2004). Significantly, we have found that FGF2 is expressed both
in the cornea and the retina in X. laevis (Fig. 2.1). In another study, FGF2 and FGFR3
(also named PFR3, or Pleurodeles homolog of FGF receptor 3) expression specifically
seemed to be correlated with Wolﬃan lens regeneration (McDevitt et al., 1997).
As described above, the 22 known members of the FGF family belong to seven sub-
families based on sequence homology (Itoh and Ornitz, 2004). It is interesting to note
that FGF1, FGF8, and FGF9 identified in our study as possible signaling candidates
involved in lens regeneration are members of three diﬀerent FGF subfamilies (Itoh and
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Ornitz, 2004). Two of the three candidates, FGF8 and FGF9, are functionally thought to
be ancestral members of their respective subfamilies in the mouse system (Itoh and Ornitz,
2008). FGF9 has been shown to interact with only FGFR2 and FGFR3, whereas FGF1
and FGF8 can activate all four FGFRs (Table 1.1; Ornitz et al., 1996). This may indicate
that a combination of FGFRs could be activated during lens regeneration. Here, we have
observed the expression of FGFR1, 2, and 3 in the cornea, so activation of these FGFRs
could be involved in triggering X. laevis lens regeneration.
As for the role of FGFR in lens regeneration, the bek isoform of FGFR2 was shown
to be present in Xenopus epidermis only in regions where the epidermis was capable of
transdiﬀerentiating into lenses (Arresta et al., 2005). Specifically, these regions include the
cornea epidermis overlying the eye and the pericorneal epidermis immediately surrounding
the eye. In that study, the authors utilized an experimental approach to impart lens-
forming competence on epidermis not normally competent to undergo transdiﬀerentiation.
This consists of implanting eye tissues beneath the target epidermis, based on the protocol
of Cannata et al. (2003). If an eye was implanted beneath head epidermis distant from the
eye (at stage 46), the head epidermis became competent to transdiﬀerentiate into lenses if
challenged later (at stage 53) by implanting this tissue into the vitreous chamber. Arresta
et al. (2005) found that this head epidermis also expressed FGFR2 IIIc after exposure
to the implanted eye. However, the authors only established a correlation between lens-
forming competence and expression of FGFR2, and did not perform any direct tests to see
if FGFR2 expression is responsible for establishing this regeneration capability.
There is evidence linking FGF pathway activation with lens development in other
vertebrates (reviewed by Robinson, 2006). In particular, regarding FGFR function,
expression of the dominant negative FGFR1 in the developing mouse lens placode (using
a Pax6 promoter expressing a dominant negative truncated form of FGFR1 ) inhibited lens
cell proliferation and diﬀerentiation, thus demonstrating that FGFR activation is necessary
for lens development (Faber et al., 2001). Similarly, a conditional knockout of FGFR2 in
the mouse lens placode produced very small or absent lenses (Garcia et al., 2005).
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The small molecule SU5402 has been shown to inhibit FGFR autophosphorylation by
competitively binding the tyrosine kinase domain of FGFR1 (Mohammadi et al., 1997).
Due to sequence conservation between the tyrosine kinase domains of FGFRs, SU5402
can inhibit the function of all four FGFRs (Delaune et al., 2005; Grand et al., 2004;
Mansukhani et al., 2005). However, SU5402 inhibitory activity is not completely specific to
FGFRs, as it has also been shown to inhibit Vascular Endothelial Growth Factor Receptor
(VEGFR) tyrosine kinase activity in NIH 3T3 cells, and to a lesser extent, Platelet-
Derived Growth Factor Receptor (PDGFR) tyrosine kinase activity (Sun et al., 1999).
Past lens regeneration studies in the newt model have investigated the FGFR pathway
using SU5402. In the case of Wolﬃan lens regeneration, Del Rio-Tsonis et al. (1998) found
that inhibiting FGFR function by using SU5402 led to inhibition of lens regeneration in
that system. More recently, Hayashi et al. (2002) used an in vitro method of culturing
newt dorsal iris cell reaggregates and established that FGF2 and FGF4 were able to induce
lens formation in these cultures. They then showed that FGFR function was necessary
for this phenomenon by inhibiting lens formation by adding SU5402. In our investigation
of Xenopus cornea-lens transdiﬀerentiation, SU5402 almost completely inhibited lens
regeneration. The observed IC50 for lens regeneration was at 5µM, less than the published
IC50 of 10-20µM for FGFR autophosphorylation in NIH 3T3 cells (Mohammadi et al.,
1997). This concentration is less than the 20µM concentration found to be eﬀective in the
newt by Del Rio-Tsonis et al. (1998) and the 10µM concentration used by Hayashi et al.
(2002), mentioned above. Taken together, the evidence suggests that FGFR activation is
both necessary (as established in the present study) and suﬃcient (as established by Bosco
et al., 1997b, see also Arresta et al., 2005) for lens regeneration in Xenopus.
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Chapter 3
Xenopus lens regeneration requires FGFR function
and is induced by FGF1, insulin, and components of
FBS
Introduction
The necessity for FGFR signaling during lens regeneration has been demonstrated by
SU5402 small molecule inhibitor experiments in both Wolﬃan lens regeneration (Del Rio-
Tsonis et al., 1998) and in Xenopus lens regeneration (see Chapter 2, Fukui and Henry,
2011). However, SU5402 also is a potent inhibitor of VEGFRs (Sun et al., 1999) and
potentially of other tyrosine kinase receptors, so an alternative explanation could be that
these earlier experiments may have demonstrated the importance of VEGF signaling.
On the other hand, FGF treatment studies suggested that FGFs may be suﬃcient to
trigger lens regeneration. In Xenopus isolated corneal tissue explants, treatment with
FGF1 appears to induce lens cell formation in these cultures (Bosco et al., 1997b; Bosco,
1998). However, the amount of FGF1 used was very high (500 ng/ml), and investigation
of potentially lower physiological concentrations of FGF (typically less than 50 ng/ml
in the intraocular space; Baird et al., 1985a; Caruelle et al., 1989) are necessary before
establishing its suﬃciency in lens regeneration. In Chapter 2 (Fukui and Henry, 2011),
evidence was presented suggesting that FGF1, FGF8, and FGF9 could play roles in
Xenopus lens regeneration, yet FGF8 and FGF9 have not been previously tested for their
potential to induce lens formation in corneal tissue.
As insulin and IGFs appear to play a role in lens development, they may also play
a role in lens regeneration. More specifically, insulin receptors and IGF receptors have
been identified to be expressed in the developing lens in various species (Hollenberg,
1975; Bassas et al., 1987; Bassnett and Beebe, 1990; Sinha et al., 1990; Jacobs et al.,
1992; Ibaraki et al., 1996; Naeser, 1997). IGF1 (also known as lentropin) is necessary
for lens fiber diﬀerentiation in lens epithelial cultures (Beebe et al., 1980, 1987). Insulin
and IGF also appear to act upon cultured lens epithelial cells to induce diﬀerentiation
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into lens fiber cells (Reddan et al., 1975; Milstone and Piatigorsky, 1977; Reddan and
Wilson-Dziedzic, 1983). Furthermore, insulin and FGF may have a synergistic eﬀect on
lens formation. For instance, combining insulin and FGF treatments appears to greatly
enhance lens fiber formation in lens epithelial cell cultures (Chamberlain et al., 1991).
A similar synergistic eﬀect was also noted for IGFs enhancing FGF-induced lens fiber
diﬀerentiation (Richardson et al., 1993; Liu et al., 1996). This evidence suggests that
investigating the correlation between insulin/IGF and lens regeneration may be useful,
especially in combination with FGF signaling.
This chapter investigates the specific necessity of FGFR signaling for lens regeneration
by conditional expression of a dominant negative FGFR (XFD) and the suﬃciency of
various FGFs and other factors such as insulin or FBS in cultures of cornea tissues in vitro.
We successfully generated transgenic F0 larvae expressing XFD upon heat shock, and then
use the transgenic larval tissues in an in vitro culture system to show that FGFR function
in the corneal epithelium is necessary for Xenopus laevis lens regeneration. We developed
a novel method that enables the corneal tissue to maintain a flattened morphology and
more eﬃciently attach and spread in culture wells. We also use this culture method to
investigate the individual suﬃciency of FGF1, FGF2, FGF8, FGF9, insulin, and FBS on
in vitro lens regeneration. Together, these results provide further evidence that the FGF
and insulin/IGF pathways play key roles in lens regeneration.
Results
Transgenic larvae express XFD upon heat shock
In order to test the necessity of FGFR function in lens regeneration, a dominant
negative FGFR1 (XFD) lacking the intracellular kinase domains was used to inhibit
FGF downstream pathway activation (Amaya et al., 1991). A transgenesis construct
was made so this dominant negative FGFR could be inducibly expressed by heat shock
(Figure 3.1; Lin and Slack, 2008). An HA tag was added to the C-terminal end of XFD
for later verification of expression. To help identify those F0 transgenic animals that
have genomic integration of the introduced DNA, this construct also contains a separate
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Figure 3.1 – Transgenesis construct for XFD expression
Diagrams of transgenesis plasmids used to explore the eﬀect of FGFR inhibition on lens
regeneration. (A) The experimental transgenesis construct containing the dominant negative
FGFR1 gene (XFD) expressed using the heat shock promoter and a gamma-crystallin
promoter ( -Cry) expressing GFP. (B) The control plasmid contains a heat shock promoter
(HSP70) expressing only the HA tag. GFP: sequence encoding green fluorescent protein,
HA: hemagglutinin tag, MCS: multiple cloning site, polyA: poly(A) tail. HGEM transgenesis
cassette based on that of Fu et al. (2002) and Beck et al. (2003).
gamma-crystallin promoter that drives expression of GFP within the lens (based on the
“heat shock green-eyed monster” construct; Fu et al., 2002; Beck et al., 2003). With this
second reporter gene, transgenic animals can be readily identified by the presence of
green fluorescent lenses. As a control, a similar construct was made to express only the
HA tag upon heat shock without XFD, but was otherwise identical to the experimental
transgenesis construct (Figure 3.1B).
Transgenic larvae were generated as described in Chapter 5 (see page 57). Successful
transgenic animals were identified by their green fluorescent lenses, indicative of GFP
transgene expression (Figure 3.2A-C). In the case of older larvae (stage 47 or later) used
in the experiments below, the fluorescence was typically bright enough to observe green
color in the eye using only ambient light (Figure 3.2A) but all cases were verified by using
fluorescence illumination. XFD expression was verified by Western blot using transgenic
larval tails collected after isolation of corneal tissues. For each transgenic tail, one half
was heat shocked (40 minutes at 34 C) and one half was left at room temperature for an
equivalent time as control. Larval tails were flash frozen using a dry ice/ethanol bath at
approximately three hours after heat shock and stored at -80 C until later homogenization
for protein expression analysis. As shown in Figure 3.2D, XFD was expressed only in those
transgenic tail halves that were heat shocked.
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Figure 3.2 – Transgenic larvae
Transgenic larvae expressing GFP in lens tissue and XFD protein upon heat shock
activation. (A) An example of an transgenic larval eye under bright field illumination. (B)
Corresponding fluorescence image of transgenic larval eye. (C) Overlay of fluorescence and
visible images shown in A and B. (D) Expression of the transgene was confirmed by Western
blot analysis shown here for 3 specimens. Expression of the XFD protein containing a C-
terminal HA tag was verified by anti-HA antibody, and anti-tubulin antibody was used as a
protein loading control. The scale bar in C indicates 500 µm.
XFD expression inhibits lens regeneration
The eﬀect of FGF pathway inhibition upon lens regeneration was assayed using an in
vitro culture method with transgenic larval eye tissue. To start these cultures, eye tissues
were assembled by combining wild type retinas (eye cups) with transgenic corneas in
modified L-15 culture medium (Figure 5.4). These eyes were then cultured in individual
wells (in 24-well plates) with 1 ml of culture medium per well. As shown previously, com-
bining a neural retina with a cornea in culture is suﬃcient to recapitulate lens regeneration
in Xenopus (Bosco et al., 1993c; Fukui and Henry, 2011). As we were investigating the
necessity of FGF pathway activation in the cornea due to presumptive FGF signaling from
the neural retina, we only needed to inhibit the FGF receptor in corneal tissue. To this
end, the use of a wild type retina excluded the possibility of transgene expression in the
cultured retina, removing the possibility/eﬀects of FGF pathway inhibition in that tissue,
which could also aﬀect its production of ligands that trigger this process. To express the
XFD (dominant negative FGFR1 ) transgene, eye cultures were heat shocked daily at 34 C
for 40 minutes each. As controls, some cultures were not heat shocked and some corneal
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tissue was derived from larvae that were generated with the control transgenesis construct,
which upon heat shock expressed only the HA tag.
Using this culture method, eyes were analyzed for lens regeneration after 14 days in
culture (Figure 3.3, Figure 3.4). Only those eyes that had corneas derived from XFD
transgenic animals, and were heat shocked, expressed XFD during the culture period. To
assay for lens formation, we used the fact that regenerated lenses will express lens proteins,
including gamma-crystallins (Henry and Grainger, 1990). Therefore, since the transgenic
construct includes a gamma-crystallin promoter expressing GFP, regenerated lenses
could be readily identified by green fluorescence (Figure 3.3B, E, H, K). Due to the use of
wild type retinal tissue, the presence of GFP expression only revealed lens cell formation
specific to the transgenic corneal tissue, removing any possibility of contamination related
to the retinal tissues and potentially any other contaminating tissues.
Lens regeneration was inhibited upon XFD expression (Figure 3.4). With the control
conditions, 1). 22/47 eyes (47%) with the control transgene and no heat shock regenerated
lenses, 2). 18/52 control non-transgenic eyes (35%) regenerated lenses with daily heat
shock, and 3). 28/65 eyes (43%) regenerated lenses using corneas containing the XFD
transgene but without heat shock. Between the three control conditions, there is no
significant diﬀerence in lens regeneration rates: all pairwise comparisons between these
regeneration rates have p > 0.1 (smallest pairwise comparison p value is 0.11). On the
other hand, only 14/66 eyes (21%) regenerated lenses under the experimental condition
(with XFD transgene and daily heat shock; rightmost bar in Figure 3.4). There is a very
significant diﬀerence between the control conditions without heat shock and the exper-
imental condition, for both controls without the XFD transgene (p = 0.0019, leftmost
bar in Figure 3.4) and with the XFD transgene (p = 0.0029, third bar in Figure 3.4). The
decrease in lens regeneration rates between the two conditions with heat shock, the control
condition without XFD in the transgenesis construct and the experimental condition with
XFD in the transgenesis construct, is also close to the threshold for significance (p =
0.053). Based on these regeneration rates, although heat shock itself may slightly inhibit
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Figure 3.3 – Regenerated transgenic lenses
Partially transgenic “eyes” cultured for 14 days at room temperature. (A-C) Cultured eye
with corneal tissue containing the control transgenic construct without XFD and without
heat shock. (D-F) Cultured eye using transgenic corneal tissue containing the control
transgenic construct treated with daily heat shock. (G-I) Cultured eye with XFD transgenic
cornea tissue with no heat shock. (J-O) Cultured eye with transgenic cornea expressing XFD
with daily application of heat shock. (A, D, G, J, M) Cultured eyes under bright light. (B,
E, H, K, N) Corresponding fluorescence images of cultured eyes. (C, F, I, L, O) Overlays
of fluorescence and visible images of eyes. Regenerated lenses were identified by their green
fluorescence (B, E, H, K). An example of an eye that did not regenerate a lens is also shown
(M-O). The scale bar indicates 200 µm. White arrowheads point to lenses.
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Figure 3.4 – Rates of lens regeneration in transgenic eye cultures
Quantification of lens regeneration rates between diﬀerent transgenic constructs with or
without XFD and either the presence or absence of heat shocks. Lens regeneration rates
of cultured eyes were assayed after 14 days in culture. The rightmost bar represents the
experimental condition in which XFD was expressed in the cornea of the cultured eye.
Numbers above each bar indicate the number of regenerated lenses observed for each
condition and the number of eyes cultured for each condition. The Y axis represents the
regeneration rate for each condition. Error bars denote Wilson score confidence intervals with
Z=1.
lens regeneration, XFD expression appears to more significantly inhibit this process,
indicating an important role in FGFR signaling in lens regeneration.
FGF signaling is suﬃcient for lens regeneration in cultured Xenopus laevis
corneas
Although various cornea culture methods have been designed for mammals, Xenopus
cornea culture methods have not been throughly developed. The few instances of culturing
larval cornea tissues appear to leave the corneas free-floating in culture medium, resulting
in the formation of small vesicular structures (Campbell and Jones, 1968; Bosco et al.,
1993c, 1994, 1997b; Bosco, 1998). We have developed a novel in vitro cornea culture
method to assay the suﬃciency of various factors for Xenopus lens regeneration that
enables the corneas to attach and spread on the bottom surface of gelatin-coated plastic
tissue culture wells, which promotes a more natural flattened morphology. In this method,
the intact larval outer cornea epithelium is isolated, oriented so the inner basal layer faces
the bottom of the culture well, and is pressed (“pinned”) onto the bottom of a gelatin-
coated culture well using the highly sharpened tips of #5 Dumont forceps (Figure 5.5).
Corneas cultured using this method will adhere to the bottom of the well and start
spreading within two days (Figure 5.5D, E). The neural retina, the natural source of lens
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regeneration factors, is omitted in these cultures to allow for assaying specific factors that
may be suﬃcient to induce lens regeneration.
In Chapter 2, we established that FGF1, 8, and 9 are diﬀerentially expressed being
much more highly expressed in the retina. Therefore, we investigated the suﬃciency of
these FGF proteins, along with FGF2, on lens regeneration (Fukui and Henry, 2011).
For FGF1, the one previously reported experiment testing its suﬃciency in Xenopus lens
regeneration used 500 ng/ml FGF1, which is a physiologically high concentration for this
ligand (Bosco et al., 1997b). Here we observed the eﬀect of various concentrations of FGF1
on in vitro cultured corneas (Figure 3.5, Figure 3.6). More specifically, cornea cultures
were treated with a range of concentrations from 10 to 1000 ng/ml FGF1 in minimal
medium (67% L-15 medium without added serum). Control cultures containing no added
FGF1 protein were also evaluated. As shown in Figure 3.5, cultured corneas quickly
attached and spread on the bottom of their respective wells. After 9 days in culture,
corneas were evaluated for regenerated lenses using anti-lens antibody staining (Henry
and Grainger, 1990), and lens formation was observed in cases following a continuum
of FGF1 treatment. In addition to positive anti-lens staining, the small lenses typically
had a raised, three-dimensional, rounded structure as opposed to the flattened epithelial
appearance of the other cultured corneal tissue.
Tiny lenses were observed upon FGF1 treatment at all concentrations, with a positive
correlation between FGF1 concentration and lens formation rate (Figure 3.6). A significant
increase in lens formation was observed with a FGF1 concentration as low as 50 ng/ml
relative to the control condition with no FGF1 treatment (p = 0.011), with the 20 ng/ml
case being close to significant (p = 0.053). At the upper end of the concentrations tested
(100 ng/ml FGF1 and above), although the increasing concentrations of FGF1 appear to
cause gradual increases in rates of lens formation, the results do not show a significant
diﬀerence between these concentrations (p = 0.36 between the 100 ng/ml and 1 µg/ml
conditions). The EC50 for FGF1 application appears to be between 20 ng/ml (19%
regenerated) and 50 ng/ml (26% regenerated), assuming a maximal lens regeneration
rate of approximately 50% at the highest FGF1 concentrations. From these observations
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Figure 3.5 – Lens regeneration in cultured corneas treatment
Corneas cultured for 9 days at with various levels of FGF1 of FGF8 treatment and then
stained using polyclonal anti-lens antibody. Corneas were treated with no FGF (A-D),
10 ng/ml FGF1 (E, F), 20 ng/ml FGF1 (G, H), 50 ng/ml FGF1 (I, J), 100 ng/ml FGF1(K,
L), 500 ng/ml FGF1 (M, N), 1 µg/ml FGF1 (O, P), and 500 ng/ml FGF8 (Q, R, S, T).
Images were taken under bright light (A, C, E, G, I, K, M, O, Q, S) and fluorescence
illumination to detect anti-lens antibody staining (B, D, F, H, J, L, N, P, R, T). Insets in C-
R contain higher magnitude images of corresponding lenses in each panel. Panels S and T are
magnified images of the lens in panels Q and R, respectively. Depressions in the culture wells
(black arrowheads in A) indicate points at which the cornea was pressed into the bottom of
the well using sharpened forceps. White arrowheads in C-P point to regenerated lenses. The
scale bar indicates 100 µm for the insets in C-R, 200 µm for all panels A-R, and 25 µm for
panel S and T.
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Figure 3.6 – Lens regeneration rates in cultured corneas upon FGF1 treatment
Quantification of lens formation rates for FGF1 treated in vitro cornea cultures. Cornea
cultures were treated for 9 days with various concentrations of FGF1 and then evaluated
for lens regeneration. The leftmost bar indicates the control condition in which no FGF1
was applied. Numbers of corneas with lens regeneration and total corneas observed for each
condition are indicated above each bar. The Y-axis indicates the regeneration rate for each
condition. Error bars show Wilson score confidence intervals with Z=1.
of regeneration rates, we can conclude that FGF1 application is suﬃcient to trigger lens
formation, and eﬀective at concentrations as low as 20 ng/ml FGF1.
In the case of FGF8, similar to the FGF1 treatments above, cornea cultures were
treated with 10, 20, 50, 100, or 500 ng/ml FGF8 in minimal medium for 9 days. Lenses
were detected using anti-lens antibody staining, as shown in Figure 3.5. However, as
shown in Figure 3.7, there were fewer cases of positive anti-lens staining observed. In
particular, there was a small amount of regeneration observed at the higher concentrations
of 100 ng/ml (1/15 regenerated) and 500 ng/ml FGF8 (3/16 regenerated, p = 0.12). No
cases of regeneration was observed at the lower concentrations of FGF8 tested. This may
indicate that FGF8 has a slight potential to induce lens regeneration at those higher
concentrations.
As for FGF2 and FGF9 treated cultures, a range of FGF concentrations up to
500 ng/ml were tested for their potential to induce lens regeneration (Table 3.1). Corneas
were cultured in minimal medium for 9 days and assayed using anti-lens antibody staining.
For corneas treated with these two FGFs, very few cases of lens regeneration was observed,
with no condition exhibiting significantly more lens regeneration than the control condition
with no FGF treatment. Therefore, FGF2 and FGF9 treatments appear not to be suﬃ-
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Figure 3.7 – Lens regeneration rates in cultured corneas upon FGF8 treatment
Quantification of lens formation rates for FGF8 treated in vitro cornea cultures. Various
concentrations of FGF8 were used to treat cornea cultures. Cultures were evaluated for
lens regeneration after 9 days. The leftmost condition is the control in which no FGF8 was
applied. The number of corneas with positive anti-lens staining and the number of corneas
observed are indicated above each bar for each condition. The Y-axis shows the regeneration
rate and the error bars show Wilson score confidence intervals with Z=1.
FGF concentration corneas exhibiting
lens regeneration
total corneas
FGF2 0 ng/ml 1 16
FGF2 10 ng/ml 0 16
FGF2 20 ng/ml 0 16
FGF2 50 ng/ml 1 14
FGF2 100 ng/ml 0 16
FGF2 500 ng/ml 0 16
FGF9 0 ng/ml 1 16
FGF9 10 ng/ml 0 15
FGF9 20 ng/ml 0 13
FGF9 50 ng/ml 1 13
FGF9 100 ng/ml 1 14
FGF9 500 ng/ml 0 16
Table 3.1 – Lens regeneration rates in cultured corneas upon FGF2 or FGF9
treatment
Lens formation rates were quantified for in vitro cornea cultures treated with FGF2 or FGF9.
Various concentrations of FGFs were used as indicated above. The number of cases with lens
regeneration was determined using anti-lens antibody staining after FGF treatment for 9 days
in culture. The total number of corneas assayed for each condition are also listed.
42
cient for inducing lens regeneration in the in vitro cornea culture assay. Together, these
FGF treatment studies suggest that FGF1 is a potent inducer of lens regeneration, whereas
FGF8 only slightly induces lens regeneration and the two other FGFs tested (FGF2 and
FGF9) do not induce lens regeneration.
Insulin, FGF1, and FBS are suﬃcient for lens regeneration in cultured corneas
We further investigated the eﬀects of FGF1, insulin, and fetal bovine serum (FBS)
treatments on lens regeneration in in vitro cultured corneas. All combinations of treat-
ments with and without insulin (5 µg/ml), FGF1 (500 ng/ml), and FBS (10% v/v) were
tested for their potential to induce lens regeneration. Corneas were cultured for 2, 5, 7,
and 9 days under each treatment condition. The presence of any regenerated lenses were
detected by anti-lens antibody staining. Interestingly, all three factors were individually
suﬃcient to trigger lens regeneration in cornea cultures (Figure 3.8, Figure 3.9). Under
almost all conditions except for the control untreated corneas with no factors added,
lenses were first detected after 7 days in culture. Across all experimental conditions, lens
regeneration rates increased with a longer culture period of 9 days. Notably, the treatment
condition with both FGF and FBS supplementation lead to lens formation earlier than
other conditions, first observed after 5 days in culture (Figure 3.9). In contrast, the highest
overall regeneration rates occurred when insulin was included.
Since insulin and FBS have never been correlated with Xenopus lens regeneration, we
sought to confirm lens regeneration using a second mode of detection. To this end, we
examined lens formation in insulin and FBS treated 9-day cornea cultures by detecting
gamma-crystallin mRNA expression via in situ hybridization to detect initial transcript
expression. gamma-crystallin is expressed in lenses during the later stages of lens regener-
ation (Brahma and Mcdevitt, 1974; Mizuno et al., 1999a; Schaefer et al., 1999). We were
able to detect gamma-crystallin mRNA in 9-day cornea cultures localized to small circular
regions, suggestive of lens formation (Figure 3.10). This experiment also demonstrates that
lens cells are forming in these cultures.
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Figure 3.8 – Cultured corneas with regenerated lenses after insulin, FGF1, and
FBS treatment
Corneas were cultured under various conditions and then stained with polyclonal anti-lens
antibody. Treatment conditions include combinations of 5 µg/ml insulin (INS), 500 ng/ml
FGF1 (FGF), and 10% v/v fetal bovine serum (FBS). (A, B) Cornea culture under control
condition with no treatments and no lens regeneration. (C, D) Cornea treated with FBS only
that regenerated two lenses. (E, F) Cornea treated with only FGF1. (G, H) Cornea treated
with FGF1 and FBS. (I, J) Cornea treated with insulin only. (K, L) Cornea treated with
insulin and FBS. (M, N) Cornea treated with insulin and FGF1 that regenerated two lenses.
(O, P) Cornea treated with all three factors. (A, C, E, G, I, K, M, O) Brightfield images
of each cornea. (B, D, F, H, J, L, N, P) Corresponding fluorescence images of each cornea
showing lens staining. Sets of 4 obvious depressions in the brightfield images indicate points
where the cornea was pressed into the bottom of the well. Arrowheads point to regenerated
lenses. The scale bar indicates 500 µm.
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Figure 3.9 – Lens regeneration rates in cornea culture with insulin, FGF1, and
FBS treatment
Lens regeneration rates in corneas cultured for 2, 5, 7, or 9 days under diﬀerent conditions.
Treatments applied include insulin (5 µg/ml), FGF1 (500 ng/ml), and fetal bovine serum
(FBS, 10% v/v). Each numerator indicates the number of corneas observed with regenerated
lenses, while the denominator indicates the total number of corneas cultured for each
condition. Conditions with lens regeneration are shaded with increasing intensity for clarity
to correlate with increasing rates of lens regeneration.
Figure 3.10 – gamma-crystallin expression in cultured corneas
In situ staining for gamma-crystallin was performed on cultured corneas. (A) Cultured
cornea treated with 5 µg/ml insulin for 9 days. (B) Cultured cornea treated with insulin and
10% v/v FBS. Positive in situ staining is indicated by dark purple coloring, in contrast to
brown coloration exhibited by occasional pigmented epithelial cells included in these cultures.
Arrowheads point to positive staining regions, and the scale bar indicates 200 µm.
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Discussion
FGFR signaling is necessary for lens regeneration
The Xenopus laevis dominant negative FGFR1 transgene (XFD) was initially devel-
oped to study Xenopus mesoderm development in early embryogenesis (Amaya et al.,
1991, 1993). XFD has since been inserted into a transgenesis construct to observe tissue-
specific eﬀects (Kroll and Amaya, 1996) and more recently for studying tail regeneration
(Lin and Slack, 2008). XFD acts by heterodimerizing with endogenous FGFRs to inhibit
FGFR downstream activation (Amaya et al., 1991). Our experiments using this dominant
negative FGFR1 transgene have shown that inhibition of FGFR function in cornea tissue
leads to inhibition of cornea-lens regeneration in Xenopus laevis as assayed in an in vitro
system. This is in agreement with our previous experiments using the small molecule
FGFR inhibitor SU5402 (see Chapter 2; Fukui and Henry, 2011). However, in those earlier
experiments there is always the possibility that the small molecule inhibitor may not have
specifically altered the FGF pathway, as SU5402 is also known to readily inhibit VEGFR
function and potentially other tyrosine kinase receptors (Sun et al., 1999). The newer
experiments reported here narrow down inhibition to the FGF pathway by expressing
a dominant negative FGFR (Amaya et al., 1991). At this point, we cannot claim that
FGFR1 is necessary as opposed to other FGFRs because the dominant negative FGFR1
can heterodimerize and inhibit the functions of FGFR1, FGFR2, and FGFR3 (Ueno
et al., 1992). In fact, we have shown that all three of these receptors (but not FGFR4)
are expressed in Xenopus cornea epithelial tissue (Chapter 2; Fukui and Henry, 2011). On
the other hand, as there is some evidence that expression of diﬀerent dominant negative
FGFRs have slightly diﬀerent developmental eﬀects (Hongo et al., 1999; Ota et al., 2009),
future experiments could investigate the eﬀects of other dominant negative FGFRs on lens
regeneration.
The corneal tissue that diﬀerentiates to form a lens during lens regeneration must
have specific receptors receiving the key signals to form lenses. It is long known that the
regenerated lens originates from the inner layer of the outer cornea in larval Xenopus
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laevis (Freeman, 1963). Past studies have strongly suggested that some key signal from the
neural retina is required to reach the cornea to trigger lens regeneration in Xenopus (Filoni
et al., 1981; Reeve and Wild, 1981; Filoni et al., 1982, 1983; Bosco and Filoni, 1992; Bosco
et al., 1993c, 1997a). We have shown that FGFR1, 2, and 3 are expressed in Xenopus
cornea tissue (Chapter 2; Fukui and Henry, 2011). By examining co-cultured transgenic
corneas with non-transgenic eye cups, we have found in this study that FGFR function
specifically in corneal tissue is important for lens regeneration. This study demonstrates a
more specific necessity than the small molecule (SU5402) experiment that inhibited FGFR
function in all the cultured eye tissues (Chapter 2; Fukui and Henry, 2011). This evidence
supports the hypothesis that a key signal for regeneration is represented by FGFs that
are transmitted to the outer cornea and detected via corneal FGFRs. As FGFR function
in the transdiﬀerentiating tissue itself appears necessary for lens regeneration, the key
signal for lens regeneration may be FGFs from the neural retina. These observations also
support the results from Chapter 2 that suggests specific FGFs (FGF1, FGF8, or FGF9)
could represent the key signal for lens regeneration, acting upon FGFR1, 2, or 3 in the
cornea to trigger lens formation (Fukui and Henry, 2011). Our results are also in line with
a previous correlation observed between FGFR2 expression and competence to form a lens
in Xenopus (Arresta et al., 2005).
Although inhibition of FGFR function inhibited lens regeneration, not all lens re-
generation was inhibited upon XFD expression. F0 animals generated using the REMI
transgenesis method are known to have diﬀerent copy numbers of the transgene inserted
into the genome (Kroll and Amaya, 1996; Sparrow et al., 2000). As we are using F0 larval
tissue, there may be a similar diﬀerence in copy numbers of the transgene for each larval
eye used, aﬀecting the strength of FGFR inhibition. More specifically, transgenic tissue
with lower copy numbers of the transgene may not have expressed enough XFD upon heat
shock to suﬃciently abolish downstream FGF signaling. In addition, some mosaicism
in expression within individual larvae has been observed using the transgenesis method
(Sparrow et al., 2000), which raises the possibility of larvae with transgenic lenses that
do not contain the transgene in all corneal cells, which leads to a lack of XFD expression
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Figure 3.11 – Interactions between candidate FGFs and FGFRs
The interactions between the candidate FGFs tested and isoforms of potential key FGFRs (b
and c) are shown. A line between a FGF-FGFR pair indicate an interaction, as determined
by Ornitz et al. (1996). Candidate FGFRs were determined in Chapter 2 (Fukui and Henry,
2011).
in some cells. Nevertheless, our experiment still shows a substantial decrease in lens
regeneration rates upon XFD expression.
FGF1 strongly induces lens formation in the cornea culture system
We have also shown through the cornea culture assay that FGF1 stimulation of cornea
cultures is suﬃcient for lens formation. This is in agreement with the study by Bosco et al.
(1997b) showing FGF1 suﬃciency for lens regeneration. We have expanded the range
of FGF1 concentrations tested and have used a diﬀerent approach to culturing Xenopus
corneas. Lenses were observed as early as 5 days in culture, consistent with Bosco et al.
(1997b) who observed lens regeneration starting at 4 days of culture. Through this study
of diﬀerent FGF1 concentrations, we have found that a FGF1 concentration as low as
20 ng/ml or 50 ng/ml is suﬃcient for inducing lens regeneration. This concentration is an
order of magnitude smaller than the previously established concentration of FGF1 shown
to trigger lens regeneration (Bosco et al., 1997b; Bosco, 1998). In our experiments, we
have also shown that FGF8 may at most be a weak inducer of Xenopus lens regeneration,
and FGF9 appears not to trigger lens regeneration. One explanation for FGF8 slightly
triggering lens formation at high concentrations may be that FGF8 shares aﬃnity for
several FGFR isoforms with FGF1 (Figure 3.11; Ornitz et al. 1996), potentially leading
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to the same FGFR signaling that triggers lens regeneration as FGF1. On the other hand,
FGF2 can activate all FGFR isoforms that FGF8 activates (Figure 3.11; Ornitz et al.
1996) but did not trigger lens formation in our assay. Thus, our results may indicate that
FGF8 can weakly trigger lens regeneration. Overall, our experiments establish a much
stronger case for FGF1 suﬃciency in inducing lens regeneration and suggest FGF8 as a
potential weak inducer of lens regeneration.
A notable diﬀerence between Wolﬃan lens regeneration and our system concerns
the specific FGF ligand suﬃcient for lens formation. FGF1, FGF8, and FGF9 were all
identified as potential key factors for Xenopus lens regeneration in Chapter 2 (Fukui and
Henry, 2011). After testing all three of these FGFs, our results indicate that FGF1 is
specifically suﬃcient for inducing lens regeneration. FGF1 has been demonstrated not to
be suﬃcient for triggering Wolﬃan lens regeneration (Hayashi et al., 2004). In Wolﬃan
lens regeneration, FGF2 appears to be the key factor that triggers lens regeneration
(Hayashi et al., 2002, 2004, 2006). Interestingly, in our examination of the eﬀect of FGF2
on in vitro cornea cultures, FGF2 did not appear to induce lens regeneration even at a
high concentration (500 ng/ml). Therefore, FGF1 and FGF2 appear to have very diﬀerent
roles in these diﬀerent lens regeneration processes.
Interestingly, the FGF1 concentration suﬃcient for lens regeneration reflects more
similarly with endogenous FGF2 levels as measured in mammals (Baird et al., 1985a,b;
Tripathi et al., 1992). For instance, the half-maximal FGF1 concentration for Xenopus
lens regeneration is similar to the 40 ng/ml FGF2 required for inducing lens fiber diﬀer-
entiation in rat lens epithelial cell cultures (Lovicu and McAvoy, 1989; McAvoy and Cham-
berlain, 1989). FGF2 is more highly expressed in the posterior chamber of the eye than
the anterior chamber in mammals. Approximately 1 ng/ml FGF2 is present in the aqueous
humor of humans, cats, dogs, and pigs (Tripathi et al., 1992), the human intraocular FGF2
level may be around 10-20 ng/ml (Baird et al., 1985a), and more than 200 ng/g FGF2
can be purified from bovine retinal tissue (Baird et al., 1985b). In Xenopus, FGF2 was
observed in both the cornea and retina (Chapter 2; Fukui and Henry, 2011). As for FGF1,
290 ng/ml FGF1 is required for half maximal stimulation in the rat (Chamberlain and
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McAvoy, 1989). Similar to the case for FGF2, FGF1 is expressed more in the retina than
the cornea: 35 ng/ml FGF1 has been measured in the bovine aqueous humor, 295 ng per
gram of tissue in the vitreous body, and 479 ng/g in the retina (Caruelle et al., 1989). We
have also detected less FGF1 mRNA in the Xenopus cornea than the retina (Chapter 2;
Fukui and Henry, 2011), but the FGF1 concentration levels measured in mammalian eye
tissues would be suﬃcient to induce lens formation in this study’s Xenopus cornea culture
system. A limitation of this study lies in the use of human recombinant FGFs to treat
Xenopus tissues: there are diﬀerences in composition between human and Xenopus FGFs
and FGFRs, including the FGF-FGFR binding sites (Plotnikov et al., 2000; Stauber et al.,
2000), so our current study may have resulted in suﬃciency of diﬀerent concentrations
of FGFs than endogenous FGF levels. Finally, the Xenopus cornea’s response to FGF1
described here may explain the results of previous xenoplastic grafting experiments
in which eyecups from other frog species (incapable of lens regeneration) were used to
implant Xenopus corneas that then exhibited lens regeneration (Filoni et al., 1979; Bosco
et al., 1991, 1993a,b): the formation of lenses in these situations was probably due to the
fact that these eyecups contain FGFs.
The roles of insulin and FBS in lens regeneration
Lens development studies have observed that insulin can enhance lens fiber diﬀerenti-
ation (Piatigorsky, 1973; Reddan et al., 1975), but there have been no past studies corre-
lating insulin with Xenopus lens regeneration. Our experiments show that 5 µg/ml insulin
treatment is suﬃcient for lens regeneration in in vitro cultured corneas. This concentration
of insulin (5 µg/ml) is routinely used as part of supplemented hormonal epithelial medium
(SHEM; Jumblatt and Neufeld, 1983) or as a supplement to MCDB 151 medium (Peehl
and Ham, 1980; Tsao et al., 1982; Kruse and Tseng, 1991) for primary mammalian cornea
epithelial cultures to facilitate cell proliferation. However, mammals do not regenerate
lenses from corneal tissue. In our case, the role of insulin may be independent of cell
proliferation, as lens regeneration has been shown to occur even without cell proliferation
(Filoni et al., 1995). Interestingly, Wolﬃan lens regeneration in newts does not appear to
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be induced by insulin treatment in vitro. A study investigating the eﬀect of various factors
on in vitro newt lens regeneration in irido-corneal complexes observed that although
0.14 IU/ml insulin (roughly 5 µg/ml) was able to induce increased iris depigmentation, the
lens regeneration rate was comparable to that of controls (Connelly, 1980). In contrast, our
experiments using a similar concentration of insulin elicited lens regeneration in Xenopus
cornea cultures. Therefore, our findings may indicate a distinct, insulin-sensitive aspect of
lens regeneration specific to Xenopus cornea tissue.
In our insulin treatments, the insulin applied is likely to have also activated IGF
receptors (Varewijck and Janssen, 2012). IGFs appear to enhance lens fiber diﬀerentiation
in vertebrate lens epithelial cell cultures (Reddan and Wilson-Dziedzic, 1983; Beebe et al.,
1987; Richardson et al., 1993). For newt lens regeneration, there is conflicting evidence
for the suﬃciency of IGF signaling. An early study found that IGF1 treatment is able
to induce newt lens regeneration (Connelly and Green, 1987), but a later study using a
higher concentration of IGF1 did not observe lens regeneration (Hayashi et al., 2002).
Introduction of IGF1 in vivo also did not trigger Wolﬃan lens regeneration (Hayashi et al.,
2004). As for Xenopus lens regeneration, an EST screen identified one encoding a protein
that interacts with IGFs, insulin-like growth factor-binding protein 2 (IGFBP2 ), which
was upregulated in the cornea during lens regeneration (Malloch et al., 2009). This finding
suggests that IGFs could play a role during lens regeneration. Since IGF has not been
directly examined yet in the context of Xenopus lens regeneration, an interesting further
experiment would be to examine the eﬀect of applying IGFs on Xenopus cornea cultures
and to characterize the expression of these proteins and their receptors in the eye.
Fetal bovine serum is routinely used for tissue culture studies. Indeed, the modified
L-15 medium commonly used for Xenopus tissue culture typically contains 10% v/v FBS
(Kay and Peng, 1991). A striking result from our experiments is that 10% v/v FBS was
suﬃcient for lens formation under our cornea culture conditions, contrasting with the
findings of Bosco et al. (1997b) in which FBS supplementation (10% v/v) did not result
in lens formation. One explanation may be the presence of variable amounts of growth
factors between diﬀerent lots of FBS that may trigger lens regeneration. In particular, FBS
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typically contains both IGF1 and IGF2 (Honegger and Humbel, 1986), as well as FGFs,
and these growth factors may have enhanced lens formation in our cultures, as discussed
above. A key diﬀerence in cornea morphology between our experiments with flattened
epithelia and those of Bosco et al. (1997b) with round vesicles may also have aﬀected
sensitivity for lens regeneration factors.
Cornea culture morphology
Our experiments are unique for Xenopus in that corneas attach and spread in the
bottom of the culture well, resulting in cornea cultures spanning a larger area. Although
Bosco et al. (1997b) utilized cultured Xenopus corneas, those corneas did not attach to
any surface and become vesicularized instead. This was simlar to an early investigation
of cultured Xenopus corneas that observed hollow vesicle formation in cases in which the
cornea tissue was not attached to any substrate (Campbell and Jones, 1968). On the other
hand, our morphology is similar to other mammalian cornea epithelial culture models,
which are typically attached onto a coated surface to form an epithelial sheet (reviewed
by Reichl et al., 2011; Sabater et al., 2013), including the earliest uses of human cornea
cultures (Thygeson, 1938). Our culture method tends to maintain a more natural state,
as these corneas exhibit epithelial morphology in vivo. Normally the inner surface of
the cornea epithelium has a specialized basement membrane (Bowman’s layer), which is
mimicked in our cultures by attachment to a gelatin coated surface. Bosco et al. (1997b)
found that following FGF treatment the entire cultured cornea appears to stain positively
for lens proteins after 7-10 days. In contrast, our culture method results in distinct lens-
like structures forming within the cultured corneas (Figure 3.5, Figure 3.8). The lens
structures formed have a three dimensional rounded appearance distinct from the flattened
epithelial-like appearance of the rest of the cornea in culture. The diﬀerences in culture
method may have caused the diﬀerence in cornea sensitivity to lens regeneration factors in
vitro in that a flattened epithelial morphology may favor the regeneration of a new lens. In
both cases, however, the resulting lens structures appear to be similar in size (on the order
of 100 µm in diameter).
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Chapter 4
Conclusions and Future Directions
This dissertation explored the relationship between FGF and FGFR signaling and
Xenopus laevis lens regeneration, which has not been extensively studied in the past.
Although much is known about the topic of FGF signaling and about lens regeneration,
the only evidence for Xenopus lens regeneration being related to FGF signaling was a
correlation between FGFR2 expression and lens regeneration competence (Arresta et al.,
2005), and a study in which a high concentration of FGF1 induced lens cell diﬀerentiation
in culture (Bosco et al., 1997b). In this dissertation, the expression of FGFs and FGFRs in
the cornea and retina were characterized, as well as the eﬀect of FGFR inhibition on lens
regeneration, and the suﬃciency of several FGFs was tested in inducing lens formation in
culture. This dissertation also includes a preliminary investigation of the role of insulin in
Xenopus lens regeneration, which has not been examined in the past.
This work expanded upon the current understanding of how FGFs and FGFRs may
play roles in lens regeneration. We have found through expression studies that FGF1,
FGF8, and FGF9 mRNA are diﬀerentially expressed between the larval retina and cornea.
These FGFs exhibited a much higher level of mRNA expression in retinal tissue than
cornea tissue, as surveyed using a semi-quantitative RT-PCR method. As the signal to
trigger lens regeneration appears to originate from the neural retina and act upon the
cornea (see Bosco et al., 1979, 1980; Cioni et al., 1982), these three FGFs (1, 8, and 9
identified in Chapter 2; see Fukui and Henry, 2011) were deemed to more likely play the
role of the key retinal signals that trigger lens regeneration. In addition, this research
found that FGFR1, FGFR2, and FGFR3 mRNA (but not FGFR4 ) were expressed in
the larval cornea, potentially acting as receptors for these ligands. Together, the findings
support the idea that FGF1, 8, and/or 9 may interact with FGFR1, 2, and/or 3 to trigger
lens regeneration.
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In addition, this dissertation further explored the functional roles of FGF ligands
and FGF receptors on lens regeneration. FGFR function appears to be necessary for
lens regeneration, as our investigations using an inhibitor (SU5402) and by expressing
a dominant negative FGFR1 resulted in inhibition of lens regeneration in in vitro eye
cultures. This suggests that one or more of these FGFRs and their isoforms are necessary
for Xenopus lens regeneration. One limitation of these experiments is that it is unclear
exactly which combination of the three receptors are necessary, since the dominant nega-
tive FGFR1 inhibits the function of other FGFRs (Ueno et al., 1992). A future experiment
is needed to determine the exact FGFR necessary via introduction of morpholinos to the
corneal tissue using lipofection or electroporation, though some functional redundancy may
also be present.
As for the FGF ligands, we have found that treating isolated cultured corneas with
FGF1 alone was suﬃcient for the diﬀerentiation of lens cells expressing lens specific
antigens at a relatively low concentration of 20 ng/ml FGF1, using an in vitro cornea
culture approach. In contrast, FGF8 also induces lens formation only in a few cases when
tested at a high concentration, and FGF2 and FGF9 do not appear to induce lens forma-
tion. Together, these results (Chapter 3) suggest that FGF1 is likely to be a key ligand
interacting with one or more FGFR in the corneal tissue to induce lens regeneration.
Research described in chapter 3 examined the potential eﬀects of insulin and FBS on
the in vitro cornea culture system. In particular, 5µg/ml insulin treatment induced lens
formation in in vitro cornea cultures. As insulin is a ligand for IGF receptors in addition
to insulin receptors, it may be the case that either insulin or an IGF ligand plays some role
in lens formation. To explore this option in the future, one could test the direct eﬀect of
various concentrations of insulin, IGF1 or IGF2 on cultured corneal tissue using the in
vitro cornea culture system developed here. To examine the potential necessity of these
ligands in lens regeneration one could express the dominant negative insulin receptor or
IGF receptors in transgenic animals, and then assess the potential for lens regeneration
in the resulting transgenic corneas. Alternatively, the expression of these receptors could
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be knocked down by electroporation or lipofection of morpholinos targeting IGF receptors
specifically into corneal tissue.
These experiments have highlighted diﬀerences in molecular mechanism between
Xenopus lens regeneration and Wolﬃan lens regeneration. Although FGF1 does not induce
Wolﬃan lens regeneration (Hayashi et al., 2004), the experiments described here indicate
that FGF1 is a key factor in Xenopus lens regeneration. In addition, Chapter 3 also deter-
mined that FGF2 treatment is not suﬃcient for Xenopus lens formation, unlike the case in
Wolﬃan lens regeneration in which FGF2 triggers lens regeneration (Hayashi et al., 2002,
2004). Furthermore, the results concerning insulin inducing lens regeneration contrasts
with the lack of eﬀect of insulin or IGF on inducing Wolﬃan lens regeneration (Connelly,
1980; Hayashi et al., 2002, 2004). Similarly, a previous study in our lab determined that
retinoic acid signaling must be decreased in the regenerating Xenopus lens (Thomas and
Henry, 2014), as opposed to the upregulation of retinoic acid signaling during Wolﬃan
lens regeneration (Tsonis et al., 2000, 2002). These diﬀerences, perhaps due to diﬀerences
regarding the specific tissues that form the lens (iris in Wolﬃan regeneration vs. cornea in
Xenopus), emphasize the importance of comparing this phenomenon in diﬀerent animals in
order to understand why it is that some can regenerate lenses while others cannot.
A future avenue of research is to investigate the downstream eﬀectors of the FGF-
FGFR interaction in regards to Xenopus lens regeneration. Despite the existence of
literature implicating a role for the downstream MAPK pathway in lens development
(reviewed in Robinson, 2006; Lovicu et al., 2011), it is unknown which FGF signaling
downstream pathways act in Xenopus lens regeneration. One method may be to use
small molecule inhibitors to test the necessity of each downstream signaling pathway such
as U0126, a MEK inhibitor (Favata et al., 1998). It should be noted that a preliminary
examination performed in our lab by Cheng (2006) investigating the MAPK pathway by
application of U0126 did not result in inhibition of lens regeneration, possibly suggesting
that a diﬀerent downstream signaling pathway (such as the PI3K/Akt pathway) may be
responsible for lens regeneration. As Sef and Sprouty are known inhibitors of the MAPK
pathway, one experiment to further assess the necessity of the MAPK pathway would be to
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overexpress these proteins in corneal tissue using transgenesis and then examine the eﬀect
on lens regeneration. More recently, a plethora of inhibitors have been developed for the
MAPK and PI3K/Akt downstream pathways (reviewed in Chappell et al., 2011; Rodon
et al., 2013), which may also be utilized to investigate the role of specific downstream
factors on lens regeneration. The PI3K/Akt downstream pathway may be interesting
to investigate due to evidence that it is activated during lens fiber diﬀerentiation in the
mammalian system (Iyengar et al., 2009; Wang et al., 2010) and is necessary for lens cell
proliferation and diﬀerentiation (Iyengar et al., 2007; Wang et al., 2009). Another method
to investigate these downstream pathways would be to knock down expression of members
of the pathways using morpholinos electroporated directly into cornea epithelial cells, and
then challenging these corneal cells to form lenses when combined with retinal tissue in the
in vitro eye culture assay.
This dissertation has expanded the knowledge of the factors involved in Xenopus lens
regeneration by demonstrating stronger evidence for the key role of FGF-FGFR function
in lens regeneration. FGF1 has been presented as a strong candidate for the key factor in
inducing lens regeneration, and FGFR signaling has been shown to be necessary for lens
regeneration. This knowledge will aid future work in other organisms to elucidate common
themes regarding development and regeneration of lenses, and may be applied towards
developing novel treatments for eye diseases to restore vision in humans. Ultimately, this
work may contribute to the formation of optimal refractive lenses, as opposed to artificial
lenses, to restore vision in humans.
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Chapter 5
Materials and Methods
Protocols
Animal care and handling
Adult pigmented X. laevis were obtained from Nasco (Fort Atkinson, WI). Fertilized
eggs were prepared and larvae were reared to various stages, as described by Henry and
Grainger (1987) and Schaefer et al. (1999). Briefly, animals are injected with human
chorionic gonadotropin (hCG; 1500 IU for the female and 1000 IU for the male; Chorulon,
Intervet, Summit, NJ) the evening before egg collection. Animals are put in a dark
room at this time and kept in the dark throughout the mating. Frogs are introduced
together in the dark the next morning and eggs start to be collected typically within two
hours. Collected eggs are dejellied by washing with 6 mM DTT and 50 mM HEPES in
1/20X NAM (see page 94). After dejellying, eggs are washed two times in 1/20X NAM
by serial transfer between solutions and then spread onto 100 mm petri dishes with
1/20X NAM. Embryos are reared for 7 days at 18 C in 1/20X NAM up to stage 43 (all
stages according to Nieuwkoop and Faber, 1956), changed daily, into fresh 100mm petri
dishes. Larvae are then transferred to room temperature into larger tanks of carbon-
filtered water after this period and fed yeast (Red Star Yeast, Milwaukee, WI) until they
are two weeks old. Larvae are then fed powdered Frog Brittle (eNasco, Fort Atkinson, WI)
until the stage desired. Larvae were staged according to Nieuwkoop and Faber (1956).
Transgenesis
F0 transgenic animals were generated for use in subsequent experiments. Several
protocols have been merged together to produce an optimum method (Amaya and Kroll,
1999; Sive et al., 2000; Smith et al., 2006; Ishibashi et al., 2008).
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Glass micropipettes (Drummond Scientific, Broomall, PA; catalog #1-000-0500) were
pulled to generate a needle tip using a PUL-1 micropipette puller (World Precision In-
struments, Sarasota, FL) using the maximum delay setting (4) and maximum heat setting
(10) on Auto mode. This produced needles that were tapered for approximately 2 cm in
length before breaking oﬀ the tip. Needle tips were broken oﬀ immediately before use to
produce a 30 -100 µm diameter opening, as described below. Depending on the number
of eggs laid by each female, up to 15 needles were typically used to generate embryos
in a single transgenesis experiment, one needle for each dish of injected eggs (each dish
holding a few hundred oocytes). A syringe injection apparatus (GENIE; Kent Scientific,
Torrington, CT) was used to control the flow of sperm nuclei during the transgenesis
protocol. For trangenesis, this flow rate is set to 0.6 µl/min. Also, for transfer of sperm
nuclei we prepared cut p200 pipette tips in advance: the p200 filter tip (Denville Scientific,
Metuchen, NJ) is cut at approximately the 10µl mark on the tip with a sharp razor blade
by hand to make an opening diameter of approximately 1.5 mm and then autoclaved in
a pipette tip box. The larger opening is to ensure that sperm nuclei will not be sheared
during transfer.
Agarose dishes were prepared by pouring 1% (w/v) agarose (Bio-Rad, Hercules, CA;
catalog #161-3101) in 1X MMR (on page 93) into small petri dishes (60 mm). Small
plastic weigh boats (1 5/8” square, Fisher Scientific, Pittsburgh, PA) were placed on top
of the molten agarose to create circular depressions (approximately 2-5 mm deep) to
accommodate the eggs, and these boats were weighted down to keep them from floating,
similar to the method in Sive et al. (2000). Once the agarose solidified, weigh boats were
removed and the agarose dishes were wrapped in parafilm and stored at 4 C for up to two
months until use. Any agarose dish that developed visible bacterial or fungal growth while
in storage was discarded.
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Preparation of sperm nuclei for transgenesis
Sperm nuclei were prepared in advance for use in the transgenesis procedure, following
the protocol of Sive et al. (2000). After preparation, sperm nuclei stock may be stored at
-80 C for several years. Details are as follows:
1. Cool 1X MMR (see page 93) on ice for washes, and prepare 30 ml fresh 2X Nuclear
Preparation Buﬀer (NPB; see page 94) solution. From this, make fresh solutions to
be used that day and store on ice (scale up volumes as needed):
(a) 40 ml 1X NPB
(b) 10 ml 1X NPB with 3% (w/v) BSA (Sigma-Aldrich, St. Louis, MO; catalog
#A7906), 10 µl/ml leupeptin (from 10 mg/ml stock in DMSO; Roche, Indi-
anapolis, IN), 0.3 mM PMSF (from 0.3 M stock in ethanol; Roche, Indianapo-
lis, IN)
(c) 5 ml 1X NPB with 0.3% (w/v) BSA
(d) 1 mL storage buﬀer (500 µL 2X NPB, 300 µl glycerol, 170 µl sterile H2O, 30 µl
10% BSA)
(e) lysolecithin solution: 100 µL 10 mg/ml L-↵-lysophosphatidylcholine (make
fresh or use stock from -20 C; Sigma-Aldrich, St. Louis, MO; catalog #L4129)
2. Euthanize male frogs and surgically isolate testes as previously described (Sive
et al., 2000, 2007a). Briefly, male animals are sacrificed by pithing and then placed
belly up on paper towels. To remove a testis, cut a vertical slit lateral to the ventral
midline, pull out the fat body (yellow tissue) from the animal, and the testis (lighter
white colored tissue) should be attached to the fat body. The testis is then freed
from the surrounding tissue using forceps.
3. Place each pair of testes collected in a 60 mm petri dish in cold 1X MMR. Remove
any large pieces of fat or tissue attached to the testes. Try to avoid puncturing a
testis and releasing sperm.
4. Rinse in cold 1X MMR three times, and then two times in cold 1X NPB.
5. Transfer a pair of testes to a dry 35 mm petri dish and macerate with sharp, clean
forceps until no clumps are visible. This takes a lot of eﬀort, but is essential for
getting a good yield of sperm nuclei.
6. Resuspend the macerate in 2 ml of cold 1X NPB (use pipettes with pre-cut tips),
and filter the macerate through 2-4 layers of sterile cotton cheesecloth into a 15 ml
tube. Use one tube for each pair of testes.
7. Use an additional 8 ml of cold 1X NPB to suspend the residual macerate and repeat
the filtering process through the same cheesecloth into the same 15 ml plastic screw
top tube for each pair of testes. Using gloves, fold and squeeze the cheesecloth
above the 15 ml tube to maximize the amount of fluid collected. After this step,
approximately 10 ml of fluid should have been collected per pair of testes.
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8. Centrifuge at 3000 rpm at 4 C for 10 minutes to pellet the sperm. Remove super-
natant, wash pellet in 8 ml cold 1X NPB by inverting, and repeat the centrifuga-
tion.
9. Resuspend in 1 ml of 1X NPB, bring to room temperature, and add 50 µl
lysolecithin. Gently mix by inverting and incubate for 5 minutes at room temper-
ature.
10. Add 10 ml cold 1X NPB with 3% BSA, 10 µl/ml leupeptin, 0.3 mM PMSF to stop
the lysolecithin reaction. Mix gently and centrifuge at 3000 rpm for 10 minutes at
4 C.
11. Wash pellet in 5 ml cold 1X NPB with 0.3% BSA, mix gently, and centrifuge again
at 3000 rpm for 10 minutes at 4 C.
12. Resuspend pellet using a cut tip in 500 µl 1X NPB with 0.3% BSA and 30% glyc-
erol. Transfer to a 1.5 ml tube and count sperm density in a hemacytometer. To
enhance sperm visibility, dilute 1:100 in 1X sperm dilution buﬀer (see page 97) and
add 1µl of 1:10 000 Hoescht dye stock.
13. Repellet and resuspend sperm nuclei in storage solution (1X NPB, 0.3% BSA,
47% glycerol) to make a final solution with approximately 100 sperm nuclei/nl.
Aliquot in single-use tubes (4 µl in each PCR tube), mixing the stock occasionally
to maintain a uniform nuclei concentration. Store at -80 C.
Transgenesis
Agarose dishes and MMR solutions should be kept in the 16 C incubator overnight
before injection, to minimize diﬀerences in temperature. Making fresh 0.1X MMR solution
(see page 93) the day before transgenesis tends to improve early embryo survival (most
critical before hatching).
1. Inject female animals with 1500 IU hCG (Chorulon, Intervet, Summit, NJ) the night
before egg collection. Keep the females isolated in individual buckets overnight in
approximately one gallon of activated carbon-filtered water and throughout the
egg-laying period. Replace the bucket water in the morning if it becomes unclean
overnight.
• Note: If the females are kept at room temperature, egg collection can start
approximately 8 hours after injection. If kept in the 18 C incubator, the female
will start to produce eggs around 10 hours after injection. It is also possible
to keep females at 16 C so eggs are produced 12 hours after injection, but this
cold temperature may cause lower quality egg production.
2. In the morning, prepare 2-2.5% solution of cysteine (Sigma-Aldrich, St. Louis, MO)
in 1X MMR (i.e. 8-10 g cysteine for 400 ml MMR). Adjust the pH of the solution to
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Figure 5.1 – Stripping eggs from a female animal
The female frog can be squeezed to collect the freshest eggs. Stars indicate the locations to
put the experimenter’s fingers to hold the hindlimbs up away from the cloaca. To strip, the
ventral side of the frog is massaged by the experimenter’s thumb in the shaded areas. The
arrows indicate the direction to massage the abdomen for maximal egg collection.
between 7.8 and 8.0 using 10 N NaOH. Keep this solution at room temperature, as
this solution will be used to dejelly the collected eggs.
3. Collect the first batch of eggs from the female into a 250 ml beaker. The female
frog may be squeezed to collect (“strip”) the freshest eggs (see Figure 5.1), or
alternatively, eggs can be collected by pipetting from the bottom of each bucket.
Stripping eggs appears to be more eﬀective at collecting the freshest (best quality)
eggs, but Sive et al. (2007b) have suggested that the natural egg collection without
stripping is less stressful to the female. Also, it should be noted that some females
did not yield many eggs by stripping.
4. Add enough cysteine solution prepared in step 2 to the 250 ml beaker to submerge
the collected eggs. The dejellying process should take about 5-10 minutes, and is
completed when the eggs appear to stack after swirling in solution without any
transparent space (indicating remaining jelly) between the eggs.
• If eggs are attached to the beaker wall or inside the plastic pipette, they can be
coaxed down by gently rinsing with cysteine solution.
5. Once dejellied, wash the eggs in 1X MMR in a beaker three times by pouring in
MMR, swirling, and decanting the solution at room temperature. While washing,
remove eggs that have a large white patch, are larger or smaller than the other eggs
from the same female, or have not maintained their spherical form. More washes
may be necessary for batches of lower quality eggs (with many white-patched or odd
shaped eggs), as these eggs are easily crushed and can cloud the MMR - the MMR
should remain clear after swirling during the last wash.
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6. Using a disposable plastic squeeze bulb pipette (Fisherbrand, Pittsburgh, PA;
catalog #13-711-7M) with the tip cut oﬀ (making a tip diameter of approximately
3-4 mm), transfer the eggs to 1% agarose dishes filled with 0.4X MMR, 4% ficoll,
and 10 µg/ml gentamicin. This injection solution should be filtered sterile using
a 0.2 µm syringe filter (Whatman, Piscataway, NJ; catalog #6780-2502) and can
be made beforehand and stored at 4 C for up to a few weeks. After transferring,
incubate the eggs at 16 C for a minimum of 5 minutes. At this point, the eggs
in dishes can safely stay in the incubator at 16 C for a few hours, although the
resulting embryos are most viable when injected immediately.
• Note: fresh eggs can be collected hourly from each female as needed for
approximately 5 hours after eggs are first produced.
7. Carefully add approximately 600 ng of linearized DNA to 4 µl of sperm nuclei stock
(aliquots of sperm nuclei are stored at -80 C). Mix by moving the pipette tip slowly
in a circular motion; do not pipet up and down as this will shear the sperm nuclei.
8. Incubate the sperm-DNA mixture at room temperature for 15 minutes. After the
incubation, dilute the sperm nuclei with 300 µl of sperm nuclei dilution buﬀer (SDB;
see page 97). Store the diluted sperm in the 16 C incubator. The sperm nuclei
ideally should be used within the first couple of hours after preparation: the quality
of these diluted nuclei will decrease over time.
9. Cut the tip of a pulled glass needle to produce a 30 - 100 µm diameter opening at
the tip. This cut can be produced quickly by stabbing the needle into a single layer
of a sheet of Kimwipe (Fisher Scientific, Pittsburgh, PA) which also tends to put a
bevel on the broken tip.
10. Using a pre-cut p200 pipet tip, mix the diluted sperm nuclei solution by pipetting
multiple times and then draw 70 µl into the tip. Insert the larger, unpulled end of
the glass needle into the pipet tip, and use capillary action to fill the needle with
liquid. Return the unused portion of the sperm nuclei solution to 16 C for future
use.
11. If there are air bubbles in the needle holder, which is filled with mineral oil, depress
the syringe on the injection apparatus to expel the bubbles. Attach the needle to
the needle holder, avoiding making air bubbles in the needle. The oil should be in
direct contact with the sperm suspension. Turn on the injection apparatus, making
sure the liquid flows at a rate of 0.6 µL/min.
• The liquid from the needle tends to flow faster for the first minute underwater
due to pressure applied during needle attachment to the injection apparatus,
leading to a much increased rate of sperm nuclei ejected. The speed of flow can
be stabilized by keeping the needle underwater towards the side of the agarose
dish for a minute before starting injections on each dish of eggs.
12. Inject the sperm nuclei into the eggs, aiming to keep the needle in each egg for
roughly 0.3 seconds per egg. Aim to insert and withdraw the needle in one smooth,
rapid movement. This time generally allows for exactly one sperm nucleus to enter
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each egg on average. Aim to inject the pigmented animal pole to make it easier to
keep track of which eggs have been injected, visible by a white dot at each injection
site.
13. After injection, return the dish with eggs to a 16 C incubator and leave them
undisturbed.
14. Repeat steps 9 to 13 for each collected dish of eggs, using a new needle for each
dish.
15. When the embryos reach the four-cell stage (approximately 3 to 4 hours after
injection), select the healthy embryos and transfer them to 0.1X MMR in 10 cm
petri dishes. The healthiest embryos have very thin visible divisions between cells,
with each of the four cells occupying an equal volume of the embryo. Unhealthy
embryos have large white caps at the injection site, and their cells appear more
separated within the embryo. Embryos with no cell divisions, a multiple of three
cells, unequal sized cells, or many cells can be discarded. The selected embryos will
show the best development if there are no more than 20 embryos placed per dish
and they are spatially separated from each other. After sorting, rear the embryos at
18 C.
16. When the embryos reach stage 12 (late afternoon on the next day), re-sort the
embryos and put them in fresh 0.1X MMR, distributed 25 embryos per dish, using
approximately 30 ml 0.1X MMR per dish. After this step, healthy embryos should
be sorted daily into fresh 0.1X MMR.
17. Sort the transgenic embryos 4 to 6 days after injection - those embryos that have
incorporated the transgenic construct can be identified by their fluorescent green
lenses. However, some of the identified embryos may not be entirely transgenic due
to transient expression of injected linear DNA (Sparrow et al., 2000) or from vari-
ability in the location for genomic integration of the transgene (Marsh-Armstrong
et al., 1999). Even so, the mosaicism exhibited by some embryos is to a much lesser
degree than with plain DNA injections, as first noted by Amaya and Kroll (1999).
Larval tissue collection and tissue culture
Eye tissues were cultured in vitro to analyze conditions required for lens regeneration.
For the SU5402 experiments, larvae were treated with 100 U/ml Penicillin and 100 µg/ml
Streptomycin in 1/20X NAM (see page 94) for three days before surgery to help reduce the
level of bacterial contamination. For other experiments, larvae were pulled directly from
the tadpole stock on the day of surgery. Pre-cut p200 filter tips were prepared beforehand
for gently transferring tissue between dishes. These tips were cut at roughly the 10 µl
mark (to make an approximately 1.5 mm diameter opening) with a sharp razor blade and
then autoclaved beforehand.
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Figure 5.2 – Lentectomy from larval eye
Steps to excise a lens from the larval eye. (1) An initial incision is made on the posterior side
of the eye through the outer corneal epithelium along an arch of approximately 120 . (2)
A deeper incision is made through this cut into the inner cornea endothelium, spanning the
pupillary space directly above the lens. (3) Using forceps, the lens is pulled out through both
incisions.
Larvae were anesthetized by the addition of MS 222 (1:3000; Sigma-Aldrich, St. Louis,
MO; Freeman, 1963) to 1/20X NAM and all surgeries were performed in this solution. The
larvae typically spent 5-10 minutes under anesthesia. For recovery after surgery, larvae
were washed three times in 1/20X NAM to remove the eﬀect of anesthesia, and then reared
in 1/20X NAM until later tissue collection. For larvae to be euthanized, larvae were kept
in MS 222 solution and then subsequently transferred to -20 C for storage.
Lentectomy and eye tissue collection
For surgical lentectomy, lenses were excised from the larval eye using number 5 Dumont
forceps and ultrafine iridectomy scissors made from number 5 Dumont forceps, following
a protocol developed previously in our lab (Schaefer et al., 1999; Carinato et al., 2000;
Figure 5.2). First, an incision was made in the posterior margin of the outer cornea of
anesthetized larvae, spanning approximately a third of the circumference of the eye. A
second incision was made in the inner cornea of the eye, spanning the pupillary space
to expose the lens (Figure 5.2). The lens was then pulled out using forceps and visually
inspected for any damage. Intact lenses appear spherical and transparent. Larvae with
damaged lenses or incomplete lens extraction were discarded.
Corneal tissue was collected from tadpoles. First, the entire circumference of the outer
margin of the cornea was cut in an anesthetized larva. Then, the outer cornea was gently
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detached from the inner cornea by cutting the connecting stalk. Upon this detachment,
the outer cornea is now completely excised from the larva. If corneas were to be frozen,
they were transferred immediately using forceps to a 1.5 ml eppendorf tube in a dry ice
and EtOH bath. Corneas were stored at -80 C. Otherwise, for cornea-containing cultures,
corneas were pipetted and transferred to a wash dish with culture medium using a cut
pipet tip, as described below.
Retinal tissue was also collected from tadpoles. In the case of retina collection, larvae
were first lentectomized, using the protocol above. Once the lens was removed, the outer
cornea was detached from the inner cornea and folded anteriorly to expose the eyecup. The
eyecup, consisting mostly of retinal tissue, was then detached from the larva by cutting the
optic stalk and muscles. For future RNA analysis, this tissue was then transferred using
forceps to a 1.5 ml tube in a dry ice and EtOH bath, then stored at -80 C. Alternatively,
the retina was pipetted to a wash dish for subsequent culturing with transgenic corneas, as
described below.
Eye culture
Larval eyes were cultured in modified L-15 media, based on a protocol previously
developed in this lab (Henry and Mittleman, 1995; Elkins, 2006). Since the tissues
collected were not necessarily sterile due to corneas having direct contact with the external
environment, antibiotics were used to prevent bacterial contamination. The antibiotics
used were marbofloxacin (10 µg/ml, Sigma-Aldrich, St. Louis, MO) to prevent the growth
of Pseudomonas and Pen-Strep (100 U/ml Penicillin and 100 µg/ml Streptomycin,
Mediatech, Herndon, VA). Amphotericin B (2.5 µg/ml, Sigma-Aldrich, St. Louis, MO) was
also used to prevent fungal contamination. Any contaminated culture was discarded.
Eyes for culture were assembled in a similar manner as previously described (Bosco
et al., 1993c; Elkins, 2006). Steps for preparing the eye culture are illustrated in Figure
5.3. First, the lens was removed from a given eye, similar to lentectomy (Fig. 5.3A-B).
Using iridectomy scissors an incision was made around the eye into the outer cornea ep-
ithelium, while maintaining the central attachment between the inner cornea endothelium
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Figure 5.3 – in vitro eye culture
in vitro eye culture system used to assay lens regeneration in stage 47-49 larvae of X. laevis.
(A) The larval eye is shown with both the inner cornea and outer cornea intact. (B) The
lens is removed following incision of the outer and inner corneas. (C-D) The outer cornea
is tucked into the vitreous chamber of the enucleated eye. (E) The eye is excised from the
tadpole and cultured in modified L-15 media with or without FGFR inhibitor (SU5402).
Structures are as labeled.
and outer cornea epithelium to help keep the tissue together. An incision was then made
in the inner cornea endothelium and the lens was removed with forceps. The outer cornea
was tucked into the opening of the vitreous chamber of the enucleated eye (Fig. 5.3C-
D). Next, the entire eye was excised from the tadpole by cutting the optic nerve and
muscle attachments, and gently washed three times in modified L-15 culture media (see
page 93) by serial transfer to separate dishes. Eyes were transferred to a 96-well plate for
SU5402 experiments (100 µl culture medium per well) using a pre-cut p200 filter tip, as
described above (Fig. 5.3E). Each eye was cultured separately, and fresh culture medium
was changed daily. If the culture developed any visible bacterial or fungal contamination,
it was discarded.
To inhibit FGFR function using SU5402, various concentrations of SU5402 diluted
from a 10 mg/ml stock in DMSO (Calbiochem, Billerica, MA) was added to modified L-15
media. Control cultures in these experiments included an equivalent final concentration of
DMSO (0.25%) in modified L-15 media, corresponding to the concentration of DMSO used
in the maximal dose of SU5402. Eyes were fixed in 3.7% formaldehyde (Sigma-Aldrich,
St Louis, MO) in modified L-15 media six days after surgery, which is ample time for the
formation of lens cells detectable by anti-lens antibody staining (Henry and Mittleman,
1995).
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Figure 5.4 – transgenic in vitro eye culture
Eye culture system used to assay lens regeneration using transgenic corneas. (A) A wildtype
larval eye is shown. (B) The lens is removed after incision of the outer and inner corneas. (C)
The cornea is removed from the wildtype eye cup. (D) The intact transgenic eye is shown,
identified by green fluorescence in the lens. (E-F) The outer cornea is excised from the eye.
(G) The eyecup from the wildtype eye and the transgenic cornea are combined and placed in
a culture well. Structures are as labeled.
Transgenic corneas were assayed for lens regeneration competence using a similar
method as above, shown in Figure 5.4. In contrast to the method outlined above for small
molecule inhibition of FGFRs, retinas were derived from wildtype animals and corneas
were from transgenic animals. Two animals were used in order to avoid detecting any
remaining lens fragments in the retina after lentectomy and to exclude any detectable
transgene expression from being in the retina. From the wildtype eye, the lens was
removed, similar to lentectomy (Fig. 5.4A-B). The retina was excised from the tadpole
and transferred to a wash dish with culture medium using a pre-cut p200 filter tip (1.5 mm
diameter opening, as described above). Transgenic eyes were identified by green fluores-
cence in the lens. From the transgenic eye, the cornea epithelium was excised and placed
in culture medium with the retina (Fig. 5.4D-F). In the wash dish, the eye structure was
assembled by gently inserting the transgenic cornea into the wildtype retina using a pair
of forceps. The assembled “eye” was then washed gently two more times by serial transfer
in modified L-15 culture medium. Single eyes were transferred to individual wells of a 24-
well plate (1 ml culture medium per well; Fig. 5.4G). Culture medium was changed fresh
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daily. Plates were heat shocked daily (40 minutes at 34 C) to express the transgene. To
heat shock, plates were placed in a constant temperature oven (DN-63, Baxter, Deerfield,
IL) set to 34 C. The oven also contained shallow tupperware dishes of water to maintain a
moist environment and to prevent desiccation. Gamma-crystallin expression is initiated at
the later stages of lens regeneration (Schaefer et al., 1999), so the associated expression of
GFP in our transgene is expected to be present later than the case of anti-lens antibody
staining which detects multiple crystallins. For these transgenesis experiments, eyes
were cultured for a longer period and assessed for lens regeneration by observing GFP
expression 14 days after surgery.
Cornea culture
In order to promote cell attachment to the bottom of the culture wells, 24-well
plates were coated with gelatin before use for cornea cultures. To coat the wells, 500 µl
0.1% gelatin (see page 90) is added to each well of a 24-well plate and left in the biological
hood for a minimum of 30 minutes. After coating, the gelatin solution is removed and
wells are washed twice with 500 µL culture medium (67% L-15, page 91) just before use.
Alternatively, gelatin-coated plates can be sealed with parafilm and stored at 4 C (with
0.1% gelatin solution) for a few months.
Corneas were cultured using various culture media in an attempt to find the optimal
culture conditions. CnT-50 medium (Zen-Bio, Research Triangle Park, NC) yielded cornea
cultures that appeared to survive for approximately two weeks. CnT-20 medium (Zen-Bio,
Research Triangle Park, NC) diluted 2:3 with deionized tissue culture water appeared to
yield increased cornea attachment relative to the CnT-50 trial and showed migrating cells
after 3 days in culture. With 67% L-15 medium (without FBS, see page 91), the cultures
survived for approximately two weeks before massive cell death occurred. The cultures
in modified L-15 medium (with FBS, see page 93) had the longest survival time (up to
the 3 months observed), as assayed by cell morphology. All media was supplemented with
marbofloxacin (10 µg/ml, Sigma-Aldrich, St. Louis, MO), Pen-Strep (100 U/ml Penicillin
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Figure 5.5 – in vitro cornea culture
Cornea culture method to assay factors suﬃcient for lens formation. (A) The intact larval eye
is shown. (B) The cornea epithelium is excised, keeping the rest of the eye structures intact.
(C) The cornea is attached to the bottom of the culture well by pushing gently with forceps
to indent the plastic and adhere the tissues. (D, E) A cornea cultured for two days using
this method in 67% L-15 medium imaged using brightfield illumination (D) and fluorescent
hoescht nuclear staining (E). The scale bar in E indicates 500 µm. Structures are as labeled.
and 100 µg/ml Streptomycin, Mediatech, Herndon, VA), and amphotericin B (2.5 µg/ml,
Sigma-Aldrich, St. Louis, MO) to prevent contamination, as described above.
The cornea epithelium is the only eye tissue used to prepare in vitro cornea cultures
(Fig. 5.5). Other eye tissues are not strictly necessary for assaying lens regeneration, as
regenerated lenses form from cells of the inner layer of cornea epithelium (Freeman, 1963).
To make cornea cultures, the cornea epithelium is first excised from the larval eye (Fig.
5.5A-B) and briefly washed once in culture medium (either 67% L-15 or modified L-15)
for a few seconds, by transferring between dishes using a cut pipet tip. A longer wash can
allow the cornea to curl up on itself, which is not desirable for the next step. After briefly
washing, the cornea is transferred to a culture well and oriented so that the inner layer
of the epithelium is facing the gelatin-coated plastic well bottom. The inner layer of the
cornea epithelium can be identified by the presence of loose tissue attached to the corneal
stalk or by the pattern of pigmentation on the pericorneal tissue when removing the
cornea. Alternatively, one can mark the cornea with two small incisions of diﬀering length
along the side of the cornea to help indicate which side is the outer or inner layer (using
the diﬀerent lengths of the incisions to orient the cornea). Once oriented, the corneal tissue
is pinned down to the bottom of the well by gently pushing down on the cornea with the
tips of the forceps (Fig. 5.5C), which resulted in indentations in the bottom of the plastic
well (Fig. 5.5D). Each cornea was anchored at 3-4 points (i.e. pressing twice, each time
with both tips of the forceps) for best attachment to generate cells that attach and migrate
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along the bottom of the well. Up to four corneas were cultured together in a single well of
a 24-well plate, and culture medium was changed every three days by exchange of 0.5 ml
medium per well. Corneal cultures were maintained for up to a few months in modified L-
15 medium using this method.
Cultured corneas were exposed to FGF1 (R&D Systems, Minneapolis, MN), FGF2
(R&D Systems, Minneapolis, MN), FGF8 (R&D Systems, Minneapolis, MN), FGF9 (R&D
Systems, Minneapolis, MN), or insulin (Sigma-Aldrich, St. Louis, MO) to investigate
their eﬀects on cornea-lens regeneration. FGF1 and FGF2 stock were initially made at a
concentration of 100 µg/ml in PBS with 0.1% BSA and stored at -80 C. FGF8 and FGF9
stock were made at a concentration of 100 µg/ml in PBS with 0.1% BSA and also stored
at -80 C. FGF stock solutions were thawed and added to culture media immediately before
use. FGF treatment concentrations ranged from 10 ng/ml to 1 µg/ml in culture media.
Control cultures without FGF were treated with an equivalent amount of PBS and BSA
as the highest concentration used for each FGF. Insulin (5 µg/ml final concentration) was
added to media during formulation of either the 67% L-15 or modified L-15 media, and
the pH of media was adjusted to 7.6 after insulin addition using NaOH. Insulin-containing
media was then filtered sterile and stored at 4 C until use.
Tissue fixation
For future lens detection by anti-lens antibody staining, cultured eye tissues were fixed
in 3.7% formaldehyde in 1/20X NAM or culture medium (modified L-15 for eye cultures or
67% L-15 for cornea cultures) after the culture period. In the case of whole eye cultures,
eyes were detached from the bottom of culture wells by pipetting or gently pushing them
with a tungsten needle. Eyes were transferred into a vial from the culture wells using a
cut pipet tip prior to fixation. Whole eyes were fixed for 1-2 hours at room temperature
or overnight at 4 C. Cornea cultures were fixed for 15 minutes at room temperature. Fixed
tissues were then washed twice each (5-10 minutes per wash) in 30% EtOH, 50% EtOH,
and 70% EtOH (all EtOH diluted with H2O). Tissue was then stored at 4 C until further
analysis (see antibody staining on page 78 below).
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DNA/RNA techniques
Restriction enzyme cutting of DNA
Restriction enzymes were used to linearize plasmids or isolate DNA fragments. Re-
striction enzymes and corresponding buﬀers were obtained from Invitrogen (Grand Island,
NY) or New England Biolabs (Ipswich, MA). For a small 10 µl digestion reaction to verify
ligation results, 0.5 µl of enzyme was used. For digestion of large amounts of DNA, enzyme
amounts were adjusted to result in a minimum of 5-fold overdigestion, as calculated from
number of enzyme units per µl and the DNA concentration. In cases with concentrated
DNA, reactions were diluted so the restriction enzyme(s) added did not exceed 10% of
the total reaction volume. 10X reaction buﬀers (supplied with restriction enzymes) and
nuclease-free water were added to make a final 1X buﬀer concentration. Reactions were
incubated for two hours at 37 C.
Cut DNA segments were purified using the GENECLEAN Turbo kit (MP Biomedicals,
Solon, OH) according to kit instructions for gel purification (to isolate a specific DNA
segment) or enzymatic solution purification. In the case of gel purification, DNA yield
appeared to improve by letting the melted gel in salt solution cool to room temperature
before initiating the centrifugation steps. All DNA was eluted using nuclease-free water
instead of the kit’s Elution Solution.
DNA ligation
Fragments of DNA were inserted into vectors to form custom plasmids. For ligations,
the Rapid DNA ligation kit (Roche Diagnostics, Indianapolis, IN) was used according
to instructions (including the recommendation for a 1:3 molar ratio of vector to insert),
with the exception that the ligation reactions were carried out for 30 minutes instead
of 5 minutes to increase yield. 1 µl of the reaction was used for each transformation
experiment described below. Completed ligation reactions were stored at -20 C.
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Growing competent E. coli stocks
Stbl3 chemically competent cells (Invitrogen, Grand Island, NY) were grown to make
additional stock for transformations. This method was kindly shared by the Fei Wang lab,
loosely based on the protocol optimized by Hanahan (1983).
1. On the first day, streak competent cell stock onto a LB plate (without antibiotics).
2. The next day, inoculate a single isolated colony in 3 ml LB media (without antibi-
otics) and grow overnight shaking at 37 C.
3. The next morning, transfer 1 ml of the overnight culture to 100 ml LB.
4. Incubate the cells while shaking until OD600 is 0.5 - 0.7 across 1 cm; do not let the
OD get higher than 0.8.
• Note that in the case of using the NanoDrop spectrophotometer (model ND-
1000, NanoDrop, Wilmington, DE) these OD values should be tenfold lower
(0.05 - 0.07) due to measuring across a 1 mm distance instead of 1 cm.
5. In the cold room, split the culture into equal amounts in 50 ml tubes. Incubate on
ice for 15 minutes.
6. Centrifuge at maximum speed (3350 rpm, 1750 g on model CL, International
Equipment Co., Needham Heights, MA) for 10 minutes in the cold room to pellet
the bacteria.
7. Discard the supernatant and add 16.6 ml of ice-cold RF1 solution (see page 96) to
each tube and resuspend. Incubate on ice for 15-30 minutes.
8. Centrifuge again at maximum speed for 10 minutes in the cold room.
9. Discard the supernatant, add 4 ml ice-cold RF2 solution (see page 96) to each tube
and resuspend. Incubate on ice for 15 minutes.
10. In the cold room, aliquot the competent cells, performing all actions under a flame
to keep the environment sterile. Make a combination of single-use 50 µl aliquots and
1 ml aliquots. All aliquots should be stored at -80 C.
11. To test the competent cells, plate cells on a plain LB plate (should develop many
colonies) and an LB plate with antibiotic (e.g. ampicillin, should develop no
colonies). As another positive control, one can transform cells with a control
plasmid and plate them on an LB plate with the plasmid’s associated antibiotic
(should develop colonies).
DNA transformation into electrocompetent cells
Transformation of DNA into ElectroMAX DH10B cells (Invitrogen, Grand Island, NY)
was performed similarly to the method provided by the company.
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1. Start warming LB plates at room temperature with the agar side up to avoid water
condensation. Alternatively, to make slightly less wet plates, warm the plates in a
37 C incubator.
2. Thaw a tube of competent cells on ice for 5-10 minutes. Mark the lid with a dot
to add to the freeze-thaw cycle count as the tube may be refrozen if there are
remaining cells. Cells from a tube with a high number of freeze-thaw cycles will not
remain as competent as cells from a fresh tube.
3. Start cooling a micro-electroporation chamber (LABRepCo, Horsham, PA) on ice.
4. In a 600 µl tube, combine 15 µl of competent cells with 1 µl of the ligation reaction,
trying not to introduce any air bubbles into the solution. Mix gently by stirring
with the pipet tip.
5. Gently pipet the competent cell mixture into the 1.5 mm electrode gap of the
electroporation chamber (LABRepCo, Horsham, PA). Make sure there are no
bubbles introduced in this process - it is preferable to leave a small volume of cells
in the pipet tip than to add a bubble.
6. Turn on the Cell-Porator E. coli Electroporation System Pulser (Gibco, Grand
Island, NY). The “voltage range” should be set to the medium setting (for an
approximately 2.5kV pulse). Put the electroporation chamber in the cooled base
container (the base is kept at 4 C for storage), and screw on the lid.
7. Push the “charge” button, and wait for the “ready” light to turn on, indicating that
the machine is fully charged. Once the machine is ready, the reading in the voltage
indicator should stay steady. Push the “trigger” button to send the electrical pulse
to the cuvette.
8. After the pulse, make sure that the mass of cells did not explode in the chamber
(i.e. see if the liquid is still in the electrode gap, not scattered all over the chamber,
the latter usually due to inclusion of air bubbles). Add 500 µl of SOC medium (in-
cluded with the ElectroMAX cells, Invitrogen, Grand Island, NY) to the chamber,
rinsing the cells oﬀ of the electrodes.
9. Use a thin sterile plastic pipet to transfer the cells to a 15 ml Falcon tube.
10. Shake the angled tube horizontally at 37 C for 1 hour to allow the cells to recover.
The horizontal angle provides an increased surface area for better aeration of the
solution. Tape the Falcon tubes onto the shaker surface to secure them.
11. If the DNA vector contains blue/white selection sequences (pGEM-T Easy), spread
100 µl of 100 mM IPTG and 20 µl of 50 mg/mL X-gal onto each LB plate while
waiting for the hour-long cell incubation. This allow time for the solutions to be
absorbed by the plates before cell plating.
• Later, this addition of IPTG and X-gal will allow blue/white selection to occur,
as blue colonies will indicate ligation products with no insert.
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12. Spread between 10 µl and 300 µl of cells under sterile conditions (near an open
flame) onto pre-warmed LB plates with antibiotic. If using the glass spreader bar,
keep spreading the cells until no visible liquid is left on the plate. Typically, two
plates with a 10-fold diﬀerence in volume were plated (such as 30 µl and 300 µl).
13. Incubate the plates at 37 C overnight, agar side up.
14. The next morning, confirm the presence of individual colonies on the plates. Wrap
the plates with parafilm and store at 4 C. Plates can be stored for up to a week.
DNA transformation into chemically competent cells
Stbl3 cells (Invitrogen) were transformed with heat shock, based on the method
provided by the company. Before starting this protocol, make sure that at least one of the
heating blocks in lab is set to 42 C and LB antibiotic plates are being pre-warmed at room
temperature.
1. Thaw one aliquot of Stbl3 cells on ice for each transformation reaction.
2. Add between 1 pg to 100 ng DNA (or 1 µl of miniprepped DNA) to the cells and
mix by stirring the pipet tip, not by pipetting up and down. Incubate the mixture
on ice for 30 minutes.
3. Heat shock the cells for 45 seconds at 42 C.
4. Return the tube to ice and incubate for 2 minutes.
5. Add 250 µl SOC medium or LB medium to each tube and transfer the solution to a
5 ml Falcon tube. Using SOC medium will yield more colonies than LB medium.
6. Shake the Falcon tube horizontally at 37 C for 1 hour. This incubation can be cut
short to as little as 30 minutes, but will decrease transformation eﬃciency.
7. Spread between 10 µl and 300 µl onto the pre-warmed LB antibiotic plates.
8. Incubate the inverted plates (agar side up) at 37 C overnight.
9. Plates can be stored at 4 C wrapped in parafilm after the overnight incubation.
Plasmid preparation via miniprep
Plasmid DNA was prepared and purified using the Wizard Plus SV Minipreps kit
(Promega, Madison, WI) with a few modifications to the protocol as described below.
1. Fill glass test tubes with 5-10 ml LB medium with antibiotic. If using ampicillin,
the frozen ampicillin stock must be fresh (within one year of aliquoting) or the
antibiotic selection may not work.
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2. Inoculate the LB medium from a fresh plate of transformed bacteria, picking a
single colony of E. coli per test tube. Alternatively, the LB can be inoculated by
bacteria from a frozen stock at -80 C.
3. Grow the bacteria by shaking overnight at 37 C.
4. The next morning, check to see if the bacteria culture grew - the LB should look
cloudy instead of clear. Make glycerin stocks by combining 738 µl of the overnight
bacterial culture with 262 µl of 50% autoclaved glycerin solution in a microcen-
trifuge tube, and store at -80 C.
5. Harvest the bacteria by centrifuging the bacterial culture in a 1.5 ml microcentrifuge
tube for 5 minutes at 10 000g (11 000 rpm on Eppendorf model 5415C). Repeat the
centrifugation until all of the bacteria grown is harvested.
6. Add 250 µl of Resuspension Solution to each tube. Resuspend the cells by pipetting
up and down.
7. Add 250 µl of Lysis Solution to each tube. Mix by inverting the tube a few times.
8. Add 10 µl of Alkaline Protease Solution. Mix by inverting the tube a few times.
Incubate for 5 minutes.
9. Add 350 µl of Neutralization Solution. Mix by inverting the tube a few times.
10. Centrifuge at maximum speed for 10 minutes at room temperature.
11. Set up the kit’s spin columns in collection tubes. Label the spin columns.
12. Decant the supernatant from the centrifuged lysate into a spin column. Centrifuge
for one minute at maximum speed and then discard the flowthrough in the collec-
tion tube.
13. Add 750 µl of Column Wash Solution and centrifuge for one minute at maximum
speed. Discard the flowthrough.
14. Add 250 µl of Column Wash Solution and centrifuge for two minutes at maximum
speed.
15. Transfer the spin column to a 1.5 ml microcentrifuge tube. Add 50 µl of nuclease
free water to the center of the spin column. Elute by centrifuging for one minute at
maximum speed. Discard the spin column after elution.
16. Measure the DNA concentration using a Nanodrop spectrophotometer. Store the
DNA at -20 C.
RNA extraction
RNA was extracted from Xenopus tissues with TRIzol (Invitrogen, Grand Island, NY),
loosely following the protocol supplied with the product, as described below. Before ex-
traction, tissues were flash frozen in a dry ice and EtOH bath and stored at -80 C. Corneas
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and retinas were collected from X. laevis larvae (stage 48-51) using fine iridectomy scissors.
Regenerating tissues were generated by removing the lens from the right eye of stage 48-
51 larvae, as described above. Corneas and retinas during lens regeneration were collected
1-, 3-, 5-, and 7- days after lentectomy. In the case of corneas, due to their small size, it is
optimal to use a minimum of 50 corneas for each RNA extraction to get the best yield per
cornea. Positive control RNA was extracted from stage 37-38 embryos.
1. Homogenize the tissue in TRIzol. Record the volume (V ) of TRIzol used at this
step - later steps will use this volume to calculate other values.
• The volume used will depend on the amount of tissue to homogenize: the
supplied protocol recommends 1 ml for every 50-100 µl tissue. This equates to
roughly to 500 µl TRIzol for every 25 cornea or retina samples, or in the case
of whole embryos, 50 µl per embryo.
• To start homogenizing, grind the tissue with a pestle in a small volume of
TRIzol. Then, quickly add the remaining volume of TRIzol and vortex to
complete the homogenization.
2. Incubate for 5 minutes at room temperature.
3. Add 0.2 ⇤ V chloroform and vortex. Incubate another 3 minutes at room tempera-
ture.
4. In the cold room (4 C), centrifuge for 15 minutes. While waiting, prepare a ice-cold
75% EtOH/25% DEPC treated H2O mixture to be used in a later step.
5. Extract the aqueous phase (top layer) into a new tube.
6. Add 0.5 ⇤ V isopropanol, then gently invert multiple times to mix the solution.
Incubate 10 minutes at room temperature.
7. Centrifuge for 20 minutes in the cold room. Immediately after centrifuging, remove
the supernate. This step may be repeated to combine RNA from a larger number
of tissue samples: add additional isopropanol solution from the previous step to the
same tube and centrifuge again.
8. Wash with V ice-cold 75% EtOH/25% DEPC H2O. Centrifuge for 5 minutes in the
cold room. Be careful not to lose the RNA pellet.
9. Remove the EtOH wash and air dry the RNA pellet for 5 to 10 minutes at room
temperature.
10. Add RNAse-free water (Sigma) to dissolve the RNA pellet. Use 5 µl for every 25
corneas and 25 µl for every 25 retinas.
11. Incubate for 10 minutes at 55 to 60 C to finish dissolving the RNA pellet. Measure
the RNA concentration using the NanoDrop spectrophotometer. Store the RNA at
-80 C.
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DNase treatment of RNA
In order to remove any residual genomic DNA from the RNA collected, RNA was
treated with DNase. The treated RNA was then purified using NucAway spin columns
(Ambion, Grand Island, NY).
1. Dilute the RNA to 200 ng/µl, adding 5X FS buﬀer to make 1X final concentration
(Invitrogen, Grand Island, NY) and a 1:25 dilution of 0.1 M DTT. For each d50 µle
reaction, add 1 µl TURBO DNase (Ambion, Grand Island, NY).
2. Incubate the reaction at 37 C for 30 minutes.
3. For each reaction, prepare one NucAway spin column (Ambion, Grand Island, NY).
(a) Settle the dry gel into the bottom of the column by tapping it on the bench.
(b) Hydrate the column with 650 µl nuclease-free H2O, replace cap, and vortex.
Let sit at room temperature for at least 5 minutes.
(c) Confirm that all of the dry gel is hydrated by visual inspection. There should
be a uniform-appearing gray color to the contents of the column. Put the gel
column in a collection tube and spin at 750g for 2 minutes at room tempera-
ture.
(d) Remove the H2O from the collection tube, then spin for 1 minute at room
temperature.
4. Apply up to 100 µl of the treated RNA to the top of the column, centering the
liquid as much as possible.
5. Put the column in an elution tube and spin at 750g for 2 minutes.
6. Measure the concentration of the eluate using the NanoDrop spectrophotometer.
Store the RNA at -80 C.
First-strand cDNA synthesis
The cDNA synthesis protocol was based on the protocols provided for SuperScript
III Reverse Transcriptase (Invitrogen, Grand Island, NY) and SuperScript II Reverse
Transcriptase (Invitrogen, Grand Island, NY). The following steps assume the desired
result is 20 µl cDNA, enough for 10 PCR reactions.
1. Calculate the volumes of RNA needed to add to each cDNA reaction. At this step,
make sure each sample will represent equal amounts of RNA (typically 10 to 100 ng
per PCR reaction, which translates to 100 to 1000 ng per cDNA reaction). Up to
8 µl of RNA stock solution may be used.
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• In the case of RT-PCR of FGFs and FGFRs, the RNA used was 100 ng per
20 µl cDNA, so each PCR reaction will use 10 ng total RNA.
2. In a PCR tube, combine: 1 µl of oligo dT primer, 1 µl of 10 mM dNTPs (Roche
Diagnostics, Indianapolis, IN), RNA as calculated above, and use Sigma ultrapure
water (Sigma-Aldrich, St. Louis, MO) to a final volume of 10 µl.
3. Using a thermocycler, incubate the tube at 65 C for 5 minutes, then cool to 4 C for
at least one minute.
4. Add 4 µl of 5X First-Strand buﬀer (Invitrogen, Grand Island, NY), 1 µl of 0.1 M
DTT, 1 µl of RNaseOUT Recombinant Ribonuclease Inhibitor (Invitrogen, Grand
Island, NY), 1 µl SuperScript II, and 3 µl Sigma water.
5. Incubate the tube at 42 C for 50 minutes, 70 C for 15 minutes, then cool to 4 C.
6. Add 1 µl RNAse H (Invitrogen, Grand Island, NY) and incubate at 37 C for
20 minutes.
7. The resulting cDNA can be stored at -20 C.
PCR portion of RT-PCR
PCR reactions were performed using Taq polymerase (New England BioLabs, Ipswich,
MA), amplified for 35 cycles. Reactions were performed as programmed below on an
DNA Engine Thermal Cycler (Biorad, Hercules, CA). PCR products were confirmed by
sequencing (Biotechnology Center, Urbana, IL).
PCR program for amplification of FGF/FGFR fragments
1: 94 C for 1 minute
2: 94 C for 1 minute
3: 60 C for 1 minute
4: 72 C for 2 minutes
5: Return to step 2 for 34 times
6: 72 C for 10 minutes
7: 4 C forever
Antibody staining
Embedding and sectioning tissues in paraplast
Eye tissues were stored in 70% EtOH at 4 C after fixation, as described above. Tissue
sections were produced and placed on subbed slides for later immunohistochemistry, such
as anti-lens staining.
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1. Wash in 95% EtOH for 15 minutes.
2. Wash 3 x 15 minutes in 100% EtOH.
3. In the chemical hood, wash 3 x 10 minutes in xylene.
4. Transfer the vials to the 60 C oven. Treat 6 hours or overnight in 50% xylene /
50% paraplast (Paraplast Plus, McCormick Scientific, St. Louis, MO).
5. Wash 3 x in 100% paraplast for 6 hours or overnight each. At the third wash, also
fill plastic boats (Peel-A-Way Mold, Truncated T12, Polysciences, Inc., Warrington,
PA) with paraplast and warm them in the embedding oven at 60 C.
6. Transfer the specimens to the wax filled boats, and incubate 6 hours or overnight.
7. Orient the specimens, making sure everything takes up at most a quarter of the
area at the bottom of the boat. Do not let specimens contact one another. Cool at
room temperature to solidify the paraplast. These boats can be stored at 4 C until
sectioning.
8. Remove the paraplast blocks from the boats and cut oﬀ the solidified meniscus
so there is a flat surface on the side opposite from the specimens. Using a heated
spatula to melt the flat paraplast surface, attach the paraplast block to a wooden
block. Carve the top of paraplast block down so that only a small rectangular area
around the specimens is present on the top surface of the block.
9. Section the specimens using the 8 µm setting on the AO rotary microtome (model
820, American Optical, Buﬀalo, NY). Arrange the sections over water on an
albumin-subbed slide (Humason, 1962). Heat the slides at 37 C overnight to dry.
The slides with attached sections can be stored in sealed containers at 4 C.
Cross-absorption of primary ↵-lens antibody serum
Polyclonal rabbit serum containing ↵-lens antibody was kindly donated by the
Grainger lab (Henry and Grainger, 1990). The rabbit serum containing antibody requires
cross-absorption against non-lens Xenopus proteins. Stage 19-24 embryos are used for this
purpose, as they have not yet developed lenses. For cross-absorption, sets of 25 embryos
can be collected and stored at -80 C until use.
1. Homogenize the embryos in an equal volume of homogenate buﬀer in a 1.5 ml tube
using a plastic pestle.
Homogenate buﬀer (1 ml)
20 µl 2M KCl
10 µl 1M Pipes
10 µl 100mM PMSF (stock PMSF is stable in isopropanol)
5 µl NP40
955 µl H2O
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2. Add 50 µl of rabbit serum and mix.
3. Incubate at 12 C for 1-2 hours, mixing occasionally.
4. Spin down the mixture for 10 minutes, then carefully remove the supernatant
(between the lipid layer and the insoluble pellet) into a new 1.5 ml tube. Avoid
collecting any lipids.
5. If needed, repeat step 4 two more times to ensure that the resulting solution is
completely free of lipids.
6. Store the cross-absorbed serum at -20 C.
Antibody staining of sectioned eye tissues on slides
Embedded eyes in paraplast blocks were sectioned on a microtome to 8 µm thickness.
Slides were stored at 4 C until staining.
1. Warm the slides to room temperature before unwrapping slides, so as to avoid water
condensation.
2. To dewax the slides, soak for 2 x 10 minutes in 100% xylene or Histo-Clear (Na-
tional Diagnostics). Note that xylene seems to work faster than Histo-Clear but is
potentially more toxic.
3. Air dry the slides at room temperature, and make sure the slides are completely
clear of wax. This should take less than one minute for xylene, and longer for Histo-
Clear.
4. Transfer slides to PBS (see page 95) for 5 minutes.
5. Transfer slides to 0.1 M glycine in PBS for 30 minutes to denature proteins.
6. Wash slides in PBS for 5 minutes.
7. Put slides in 5% (w/v) Carnation nonfat dry milk in PBS for 45 minutes to block.
8. Place the slides in moisture chambers and add 200-300 µl of primary antibody
solution to completely cover the top surface of the slide. The moisture chambers are
essential for preventing the slides from drying out. Slides are elevated using the tops
of 35 mm petri dishes to prevent wicking of the solution. Incubate the slides in the
moisture chamber for at least two hours at room temperature or overnight at 4 C.
Slides must be completely level to prevent pooling of the solution.
• In the case of lens antibodies (Henry and Grainger, 1990), dilute the cross-
absorbed lens antibody solution 1:50 into the blocking solution (5% dry milk).
9. Collect the primary antibody solution from the slides, and transfer the slides to
PBS. The primary antibody solution can be stored at -20 C and used approximately
three times.
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10. Wash slides 2 x 10 minutes in PBS.
11. Dilute the secondary antibody 1:100 in 5% dry milk and 1X PBS. For lens staining,
the secondary antibody is goat anti-rabbit rhodamine IgG (Jackson ImmunoRe-
search Laboratories, Inc.), and lens cells should be fluorescent red.
12. Place slides in moisture chambers and add 200 µl of secondary antibody solution to
each slide, covering the entire top surface of the slide. Let the slides incubate for at
least one hour at room temperature or overnight at 4 C.
13. Wash the slides for 2 x 10 minutes in PBS and mount using a 80% glycerol /
20% PBS solution, with 1:10 000 dilution of hoescht 33342 (Molecular Probes) for
nuclear staining. Store slides at 4 C.
Antibody staining of whole corneas
Corneas cultured in 24-well plates can be stained with a similar protocol as for
sectioned eye tissues, but the tissue remains attached to the culture wells.
1. Fix corneas in their wells in 3.7% formaldehyde in 67% L-15 (without serum) for
15 minutes at room temperature.
• At this point, corneas can be washed in 70% ethanol twice for 10 minutes each
and then stored at 4 C until staining.
2. Wash the corneas in 2 ml/well PBTw (PBS with 0.1% Tween 20) for 5 minutes.
3. Wash in 2 ml/well PBS for 2 x 10 minutes.
4. Block using 1 ml/well 5% dry milk in PBS; incubate for 45 minutes.
5. Incubate with 200 µl/well primary antibody for 2 hours at room temperature or
overnight at 4 C.
• To make the ↵-lens antibody solution, dilute cross-absorbed antibody 1:50 in
PBS with 5% milk, or use a previously used, diluted stock taken from -20 C.
Diluted primary antibodies can be used up to three times.
6. Wash with 2 ml/well PBS for 2 x 10 minutes.
7. Incubate with 200 µl/well secondary antibody for 1 hour at room temperature or
overnight at 4 C. For lens staining, use a 1:100 dilution of the rhodamine goat anti-
rabbit secondary antibody in PBS with 5% dry milk.
8. Wash 2 x 10 minutes in PBS.
9. Add mounting media (80% glycerol / 20% PBS / 1:10 000 Hoescht) to wells, and
store plates in dark.
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Statistical analysis for lens counting
Since the inhibition assays were expected to yield significantly low regeneration rates,
Fisher’s exact test under the one-tailed condition was used (Yates, 1934; Irwin, 1935).
Comparisons with p values less than 0.05 were considered to be significant.
Protein analysis
Tissue collection and quantification for protein analysis
Tissue samples were flash frozen using a dry ice and ethanol bath at the time of
collection and stored at -80 C until analysis. For tail samples, individual tail halves were
transferred using clean forceps into separate 1.5 ml tubes and tissue homogenization was
performed in 100 µl Lysis buﬀer (see page 92) for each tail sample. For cornea cultures,
culture medium was removed and 100 µl Lysis buﬀer was added to each well containing
4 corneas. The culture plates were then rocked for 10 minutes, and the lysed solution was
collected. To remove insoluble material, homogenized tissue samples were spun down at
maximum speed for 5 minutes at room temperature, and the supernatant was collected.
Protein quantification was performed using a BCA kit (Thermo Scientific, Waltham,
MA), with some modifications to the provided instructions due to the low volumes
required for the Nanodrop spectrophotometer. Although attempts were made to use the
Bradford method (Bradford, 1976), there was too much detergent in the lysis buﬀer for
eﬀective protein quantification. In the modified BCA quantification method, only 5 µl of
each homogenized tissue sample was combined with 5 µl lysis buﬀer and 10 µl BCA work-
ing solution. In the case of larval tail samples, serial dilutions were made (by addition of
equal volumes of lysis buﬀer and BCA working solution) to accommodate the wide variety
in tail sizes. Samples were incubated at 37 C for 2 hours before measurement using the
BCA mode on the Nanodrop software. After quantification, protein concentrations were
adjusted to be equal by addition of protein sample buﬀer (see page 96).
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Preparation of polyacrylamide gels for Western blotting
1. Assemble the gel casting apparatus (Bio-Rad, Hercules, CA), making sure that the
glass plates are clean and oriented correctly. We use the 0.75 mm spacers for mini
gels with either a 10-well or 15-well comb.
2. Prepare the resolving gel solution (see table below) according to the desired per-
centage gel. Do not add TEMED until ready to pour. Required reagents are listed
below for a single gel:
reagent 7.5% gel 10% gel
1.5 M Tris-HCl, pH 8.8 1 ml 1 ml
20% (w/v) SDS 20 µl 20 µl
acrylamide/bis-acrylamide (30%) 1 ml 1.33 ml
10% ammonium persulfate 40 µl 40 µl
TEMED 2.4 µl 2.4 µl
H2O 2 ml 1.67 ml
3. Using a p1000 pipet, gently pipet 4 ml of the resolving gel solution per gel, or until
the solution reaches 1-2 cm below the lip of the glass plate. Then, carefully add
1 ml of H2O or 100% ethanol to the top of the resolving gel. Ethanol is preferred for
adding to the top of the resolving gel, since it is much easier to make the mistake of
pipetting H2O too quickly than to pipet ethanol too quickly. Make sure there are no
bubbles in the gel and the solution isn’t leaking out at the bottom of the gel. Allow
30 minutes for the gel to set.
4. Prepare the stacking gel solution. Do not add TEMED until ready to pour.
reagent 4% stacking (2 ml)
0.5 M Tris-HCl, pH 6.8 500 µl
20% (w/v) SDS 10 µl
acrylamide/bis-acrylamide (30%) 333 µl
10% ammonium persulfate 20 µl
TEMED 2 µl
H2O 1135 µl
5. Pour out the H2O/EtOH overlay on the resolving gel and use a kimwipe to remove
the excess fluid.
6. Gently pipet the stacking gel solution until the solution reaches the lip of the glass
plate. Insert the comb carefully, making sure there are no bubbles under or between
the teeth. Let the gel set for 30 minutes.
7. Once the gel sets, carefully remove the comb so that the wells maintain their rectan-
gular shape. For the cleanest Western blots, use the gels immediately. Alternatively,
gels can be wrapped in saran wrap with wet paper towels and stored at 4 C for up
to a few weeks.
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Western blot
To prepare the protein samples, add 2X protein sample buﬀer (see page 96) and boil
for 5 minutes. These protein samples can then be stored at -20 C until use.
1. Assemble the gel apparatus (Biorad, Hercules, CA) and fill the middle chamber
completely with Tris-SDS-Glycine buﬀer (page 97). Fill the outer chamber with
Tris-SDS-Glycine buﬀer, but this buﬀer is only required up to the bottom of the gel
in the outer chamber. If the buﬀer leaks from the middle chamber, re-assemble the
gel apparatus so it doesn’t leak.
2. Wash all the wells with buﬀer using a p200 pipet.
3. Load the unused wells with protein sample buﬀer to limit the lower expansion of the
other lanes.
4. Load the protein standard. Use 5 µl of the Precision Plus Protein Standard (Biorad,
Hercules, CA) or 2 µl of PageRuler Prestained Protein Ladder (Thermo Scientific,
Waltham, MA) in a single lane.
5. Load the protein samples slowly into wells, making sure the samples flow into the
correct well.
6. Run the gel at 150 V until the dye front moves to the bottom of the gel. This
should take approximately one hour. While running, check the gel apparatus
periodically to make sure that the buﬀer hasn’t leaked out of the middle chamber.
7. Soak the fiber pads, filter paper (Whatman Chromatography Paper, Whatman,
Piscataway, NJ, catalog number 3030917), and nitrocellulose membrane (Bio-Rad,
Hercules, CA) in Western blot transfer buﬀer (see page 98) in a shallow tupperware
container.
8. Disassemble the gel apparatus and assemble the gel transfer apparatus in the cold
room. Make sure there is ice in the ice dam and fill partially with transfer buﬀer.
Add a small stir bar to the chamber.
9. Carefully remove the gel from the glass plates and put it with the nitrocellulose
membrane in transfer buﬀer.
10. To assemble the protein blot sandwich, put the fiber pads on the outside, then two
pieces of filter paper, then the nitrocellulose membrane and gel in the middle. To
keep track of the sandwich orientation, make sure the gel is on the black side of
the gel holder cassette and the transfer membrane is towards the clear side of the
cassette.
11. Place the cassette into the transfer apparatus so that the black side of the cassette
is oriented towards the black (negative) side of the electrode assembly. Fill the rest
of the chamber with transfer buﬀer.
12. Connect the electrodes and transfer at 80V for an hour in the cold room. Set the
stir bar to the slowest possible setting without stalling.
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13. Remove the nitrocellulose membrane and stain with Ponceau S stain (page 95) for
5 minutes.
14. Destain with dH2O for 5 minutes.
15. With a clean razor blade, cut the nitrocellulose membrane down to the area that
contains the ladder or where it is stained. The cut-down membrane should fit in the
small clear plastic boxes (approximately 7 cm by 5 cm) for washing.
16. Wash in 1X TBST (page 97) for 2 x 10 minutes.
17. To make Blocking Buﬀer, add 5% dry milk to 1X TBST (2.5 g for 50 ml). Vacuum
filter the blocking buﬀer using Whatman paper to remove large particles.
18. Block for 1-2 hours at room temperature.
19. Dilute primary antibody in 5 ml 1X TBST with 1% dry milk (4 ml TBST and 1 ml
Blocking Buﬀer) or thaw a used primary antibody solution. Immerse the membrane
in antibody solution, shaking overnight at 4 C. The primary antibody solution can
be collected and stored at -20 C to be used up to three times.
20. Wash in 1X TBST for 2 x 10 minutes.
21. Dilute the secondary antibody 1:5 000 in 1X TBST with 1% dry milk. Incubate the
membrane for 1-2 hours at room temperature in secondary antibody solution.
22. Wash in 1X TBST for 2 x 10 minutes.
23. Develop the membrane using the SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientific, Waltham, MA) according to the manufacturer’s
instructions. Specifically, mix the kit solutions 1:1, making 4ml total volume per
membrane. Drain the membrane using a paper towel, lay it on top of a sheet of
saran wrap (protein side up), and pipet the mixed solution onto the membrane.
Incubate for 5 minutes, and then drain oﬀ the substrate.
24. Wrap the membrane using saran wrap and expose to film (Denville Scientific,
Metuchen, NJ) in a dark room for 30 seconds. The exposure time can be adjusted
depending on the intensity of the signal. Develop the film using a Kodak X-OMAT
2000A processor (Eastman Kodak, Rochester, NY).
In situ Hybridization
Preparation of torula RNA to be used in hybridization buﬀer
A phenol-chloroform extraction was performed on crude yeast RNA to remove any
possible contaminants. This RNA is then used in the Hybridization buﬀer (page 91) for
the in situ experiment described below.
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1. Combine 1 g crude yeast Torula RNA (Sigma, St. Louis, MO, catalog number R-
6625) and 10 ml DEPC treated H2O (page 90) into a 50 ml conical screw cap tube.
Heat at 56 C for 20 minutes while rocking - there will be a lot of solid, insoluble
material left in the water.
2. Centrifuge at the highest speed setting (3350 rpm, 1750 g on model CL, Interna-
tional Equipment Co., Needham Heights, MA) at 4 C for 5 minutes to pellet the
insoluble material. Transfer the supernatant to a new conical tube.
3. Add 8 ml pure phenol (stored at 4 C), 1960 µl chloroform, and 40 µl isoamyl
alcohol. Shake well and then centrifuge at maximum speed for 10 minutes.
4. Recover the aqueous layer into another conical tube. Extract again with an equal
volume of chloroform/isoamyl alcohol (24:1 ratio). Mix well and centrifuge for 10
minutes at maximum speed.
5. Recover the aqueous layer into another conical tube. For every 1 ml of liquid
recovered, add 100 µl NaOAc (3M stock at pH 5.2 in DEPC H2O) and 2.75 ml ice-
cold 100% ethanol. The RNA should immediately start precipitating.
6. Complete the RNA precipitation by cooling at -20 C overnight or -80 C for 1 hour.
7. Centrifuge sample at maximum speed for 15 minutes at 4 C.
8. Remove the supernatant. Wash the pellet with ice-cold 70% ethanol in DEPC H2O.
Spin again for 5 minutes at 4 C.
9. Remove the supernatant. Dry the pellet in the tube.
10. Resuspend the pellet in 5 ml DEPC H2O.
11. Quantitate the RNA sample and dilute to a final concentration of 40 mg/ml using
DEPC H2O. Aliquot 1.25 ml per tube (enough for 50 ml Hybridization buﬀer) and
store at -80 C.
Preparation and quantification of DIG-labeled RNA probes
RNA probes are labeled with digoxigenin (DIG) for later detection. It is important
that gloves are worn and aerosol-free tips are used, in order to prevent RNase contamina-
tion.
1. PCR amplify the DNA fragment to be used as the template for the later RNA
transcription reaction. Use SP6, T3, or T7 primers as required.
PCR program for making DIG-labeled probes
1: 94 C for 1 minute
2: 94 C for 1 minute
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3: 60 C for 1 minute
4: 72 C for 1 minute
5: Return to step 2 for 34 times
6: 72 C for 10 minutes
7: 4 C forever
2. Set up the DIG-labeling reactions for each primer used as shown below, to make a
total of two 20µl reactions.
SP6 T3 T7
Ambion RNA polymerase (20U/µl, primer specific, Ambion,
Grand Island, NY)
2µl 2µl 1µl
10X transcription buﬀer (primer specific, Ambion, Grand
Island, NY)
2µl 2µl 2µl
DIG-labeling mix (Roche Diagnostics, Indianapolis, IN) 2µl 2µl 2µl
PCR reaction from step 1 7µl 7µl 7µl
RNase-free H2O 6.5µl 6.5µl 7.5µl
RNase inhibitor (Ambion, Grand Island, NY) 0.5µl 0.5µl 0.5µl
3. Incubate the reactions at 37 C for 90 minutes.
4. Use Nuc-Away columns (Ambion, Grand Island, NY) to purify the RNA reactions
immediately after the reactions are complete, using the steps described in the Nuc-
Away column instruction manual.
(a) Settle the dry gel into the bottom of the column by tapping it on the bench.
Hydrate the column with 650 µl nuclease-free H2O, replace cap, and vortex.
Let sit at room temperature for at least 5 minutes.
(b) Confirm that all of the dry gel is hydrated by visual inspection. There should
be a uniform-appearing gray color to the contents of the column. Put the gel
column in a collection tube and spin at 750g for 2 minutes at room tempera-
ture.
(c) Remove the H2O from the collection tube, then spin for 1 minute at room
temperature.
(d) Apply the results of the DIG-labeling reaction to the top of the column,
centering the liquid as much as possible. Put the column in an elution tube
and spin at 750g for 2 minutes.
(e) An optional step to verify the result of the transcription reaction is to run 1 µl
of the purified product on a RNA gel.
5. For quantification of the transcription results, a dot blot is performed to quantify
RNA. First, use DEPC treated H2O to make 10-fold serial dilutions of labeled
control RNA (Roche Diagnostics, Indianapolis, IN) and the transcribed DIG-labeled
probes. Essentially, add 1 µl RNA to 9 µl DEPC H2O to make the 1:10 dilution,
and then make a 1:100 dilution using the 1:10 dilution and DEPC H2O for each
transcribed RNA sample.
6. On a positively charged nylon membrane, spot 1 µl of each sample dilution. Label
the samples on the membrane using a Skilcraft government pen.
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7. Fix RNA to the membrane using a Spectrolinker UV Crosslinker (model XL-1500,
Spectronics, Westbury, NY) using the “Optimal Crosslink” button.
8. Wet the membrane with MAB (page 92).
9. Incubate the membrane in 5 ml Northern blocking solution (add 3 ml 10% BMB
stock in -20 C freezer, to 12 ml MAB) for 5 minutes at room temperature.
10. Dilute 2 µl anti-DIG-AP antibody (Roche Diagnostics, Indianapolis, IN) in 10 ml
Northern blocking solution. Incubate the membrane in anti-DIG-AP for 5 minutes
at room temperature.
11. Wash the membrane twice for 5 minutes each in MAB at room temperature.
12. Make AP buﬀer (5 ml 1 M Tris pH 9.5, 2.5 ml 1 M MgCl2, 1 ml 5 M NaCl, bring
up to 50 ml with DEPC H2O). Incubate the membrane in 10 ml AP buﬀer for 2
minutes at room temperature.
13. Make color substrate solution by adding 33.75 µl NBT (100 mg/ml stock) and
35 µl BCIP (50 mg/ml stock) to 10 ml AP buﬀer. Incubate the membrane in
color substrate solution in the dark for 1 hour, checking every 15 minutes for color
development.
14. To stop the reaction, wash with AP buﬀer for 5 minutes at room temperature.
15. Wash the membrane twice for 5 minutes each in MAB and then let the membrane
dry on a paper towel.
16. Observe the developed color on the membrane. Ideally, the spots corresponding to
the probe RNA should develop exactly as dark as the control RNA.
In situ hybridization
1. For corneal tissues to be stained using in situ hybridization, fix in MEMFA (see
page 93) within the 24-well plate for 30 minutes. Samples can then be washed with
100% methanol twice for 10 minutes each and stored at -20 C until use.
2. Hydrate each well by washing at room temperature in each solution below for
5 minutes each, making sure to keep the fixed tissue wet at all times, using 2 ml per
well:
(a) 100% methanol
(b) 75% methanol and 25% PTw (see page 96)
(c) 50% methanol and 50% PTw
(d) 25% methanol and 75% PTw
(e) 3 washes of 100% PTw
3. Make Proteinase K solution by adding 25 µl Proteinase K (10 mg/ml stock) to
25 ml PTw. Wash in Proteinase K solution for 5 minutes at room temperature.
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4. Make 2 mg/ml glycine solution by adding 0.05g glycine to 25 ml PTw. Wash in
glycine solution for 5 minutes at room temperature.
5. Wash twice in PTw for 5 minutes each.
6. Thaw 20% paraformaldehyde stock (see page 95) from -20 C freezer. Add 5 ml
20% paraformaldehyde to 15 ml PTw to make 4% paraformaldehyde solution. Refix
in paraformaldehyde for 20 minutes.
7. Wash twice in PTw for 5 minutes each at room temperature, using 2 ml per well.
8. Remove half of PTw and add 250 µl hybridization buﬀer (page 91) to each well.
9. Replace all of the solution in each well with 500 µl hybridization buﬀer. Place on
rocker in oven set to the slowest speed at 60 C for 10 minutes.
10. Incubate with fresh hybridization buﬀer (500 µl per well) at 60 C for a minimum of
2 hours while rocking.
11. Make probe solution by adding 5 µl DIG-labeled probe to 500 µl hybridization
solution for each well. Incubate probe solution for 30 minutes at 60 C.
12. Replace the hybridization buﬀer in the wells with probe solution (500 µl per well),
and rock overnight at 60 C.
13. In the morning, wash with hybridization buﬀer for 10 minutes at 60 C.
14. Make 2X SSC + 0.3% CHAPS solution: add 0.15 g CHAPS (Sigma-Aldrich, St.
Louis, MO) to 5 ml 20X SSC (page 97) in a 50 ml conical. Fill to 50 ml with DEPC
H2O.
15. Wash with 50% hybridization buﬀer and 50% 2X SSC + 0.3% CHAPS at 60 C for
10 minutes while rocking, using approximately 500 µl solution per well.
16. Wash with 25% hybridization buﬀer and 75% 2X SSC + 0.3% CHAPS at 60 C for
10 minutes while rocking, using approximately 500 µl solution per well.
17. Decrease the oven temperature to 37 C. Wash twice in 2X SSC + 0.3% CHAPS for
20 minutes each at 37 C, using approximately 1 ml per well.
18. Make RNase solution by adding 40 µl RNase A (Roche Diagnostics, Indianapolis,
IN) and 20 µl RNase T (Sigma-Aldrich, St. Louis, MO) to 20 ml 2X SSC +
0.3% CHAPS. Treat wells with RNase solution for 30 minutes at 37 C.
19. Make 2X SSC by diluting 20X SSC with DEPC H2O. Wash twice in 2X SSC at
room temperature for 10 minutes each.
20. Wash twice in 0.2X SSC for 30 minutes each at room temperature.
21. Wash twice in MAB (page 92) for 10-15 minutes each.
22. Add 3 ml BMB (10% stock in -20 C freezer) to 12 ml MAB to make 2% BMB
buﬀer. Wash in this buﬀer for 60 minutes at room temperature.
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23. Combine 9 ml MAB, 3 ml BMB, and 3 ml lamb serum (Gibco, Grand Island, NY).
Wash in this solution for 60 minutes at room temperature, using 0.5 ml per well.
24. Add anti-DIG antibody (Roche Diagnostics, Indianapolis, IN) to the solution above
(with MAB, BMB, and lamb serum) at a 1:2000 dilution. Fill each well with 0.5 ml
of antibody solution and shake overnight at 4 C.
25. Wash five times for 60 minutes each in MAB.
26. Wash twice in Alkaline Phosphatase Buﬀer (5 ml 1 M Tris pH 9.5, 2.5 ml 1 M
MgCl2, 1 ml 5 M NaCl, 50 µl Tween 20, 0.06 g lavamisol (Sigma-Aldrich, St. Louis,
MO), fill to 50 ml with DEPC H2O) for 5 minutes each at room temperature.
27. Add 500µl BM Purple (Roche, Indianapolis, IN) per well and develop in the dark
at room temperature for a few hours. It is important to avoid any light exposure to
the solution. If there is no signal after a few hours, develop in the dark overnight at
4 C. The signal may take a few days to develop, in which case BM Purple should be
replaced daily.
28. Wash in Alkaline Phosphatase Buﬀer for 10 minutes at room temperature to stop
the reaction.
29. Wash twice in 1X PBS for 5 minutes each at room temperature.
30. Refix in 4% paraformaldehyde for a few hours.
31. Wash twice in 1X PBS for 5 minutes each.
32. Add 80% glycerol / 20% PBS solution and store refixed samples at 4 C. Make sure
the plates are sealed well with parafilm to avoid desiccation.
Solutions and recipes
DEPC (diethylpyrocarbonate) treated H2O
Add 1ml DEPC (Sigma-Aldrich, St. Louis, MO) to 1 L dH2O in chemical hood.
Vigorously shake the bottle and vent twice. Keep the bottle slightly open in the chemical
hood overnight, and then autoclave. Note that DEPC is dangerous!
0.1% gelatin
Use a clean, detergent-free bottle to make this solution.
0.1 g Knox unflavored gelatine (Kraft Foods, Northfield, IL)
100 ml H2O
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Autoclave to sterilize. Note that the gelatin should dissolve in the H2O in the auto-
clave.
Hybridization buﬀer (100 ml)
50 ml 50% deionized formamide (stock in -20 C freezer)
25 ml 20X SSC (see page 97)
2.5 ml Torula RNA (see page 85)
2 ml 5 mg/ml Heparin (stock stored in -20 C freezer)
2 ml 50X Denhardt’s solution (stock stored in -20 C freezer)
100 µl Tween 20
0.1 g CHAPS
1 ml 0.5M EDTA
Fill to 100 ml with DEPC H2O.
67% L-15 medium (250 ml)
2.28 g L-15 powder (Invitrogen, Grand Island, NY, catalog #41300-021)
2.5 ml Pen-Strep (10 000 U/ml Penicillin and 10 mg/ml Streptomycin stock;
Mediatech, Herndon, VA, catalog #30002CI)
Fill to 250 mL with 18 M⌦ deionized, tissue culture grade H2O
Adjust pH to 7.6, filter sterilize using a 500 ml Nalgene vacuum filter (Thermo
Scientific, Waltham, MA, catalog #291-4520) in biological hood, and store at 4 C.
LB medium
25 g Miller LB powder (Fisher Scientific, Pittsburgh, PA)
Dissolve in 1 liter H2O
Aliquot into 250 ml bottles. Autoclave on same day.
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LB ampicillin plates (makes one sleeve of plates)
12.5 g Miller LB powder (Fisher Scientific, Pittsburgh, PA)
7.5 g Bacto agar (Fisher Scientific, Pittsburgh, PA)
Dissolve LB in 500 ml H2O
Autoclave the LB/agar broth immediately after mixing, keeping the stir bar in the
bottle. After autoclaving, let bottle cool down to approximately 55 C while stirring
slowly. Add 500 µl 100 mg/ml ampicillin to make a final concentration of 100µg/ml
ampicillin. Quickly pour into medium sized (100 mm) petri dishes, completely covering
the bottom of each dish (approximately 1/4 full) while trying to avoid producing air
bubbles.
Lysis buﬀer
Make this solution fresh for each use. Final concentrations of each ingredient are listed
below.
1X protease inhibitor (cOmplete, Mini, EDTA-free, Roche, Indianapolis, IN;
catalog #11836170001; make the 10X stock according to instructions and
store at -80 C)
1X phosphatase inhibitor (PhosSTOP, Roche, Indianapolis, IN; make 10X
stock according to instructions and store at -20 C)
1 mM EDTA (dilute from 0.5 M EDTA stock)
1X PBS (dilute from 20X stock; see page 95)
1% NP-40
Fill with H2O
MAB (Maleate buﬀer, 1 L)
11.61 g maleic acid
8.76 g NaCl
First, fill a 1L bottle to approximately 800 ml with H2O and stir to dissolve ingredi-
ents. Adjust the pH to 7.5. This pH adjustment will require a lot of NaOH: drop NaOH
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pellets into the solution until the pH gets close to 7, and then fine tune using 10N NaOH.
Fill to 1L with H2O, treat with DEPC, and autoclave.
MEMFA (50 ml)
This solution is only eﬀective for one week after being made.
5 ml 1 M MOPS pH 7.4
1 ml 100 mM EGTA pH 8.0
500 µl 100 mM MgSO4
5 ml 37 % formaldehyde
38.5 ml DEPC H2O
10X MMR (Marc’s Modified Ringers, 1 liter)
This recipe is from Sive et al. (2000). Use a detergent-free bottle when making this
solution.
58.44 g NaCl
1.4912 g KCl
2.033 g MgCl•6H2O (to make 10 mM)
2.940 g CaCl2•2H2O (to make 20 mM)
11.925 g HEPES (to make 50 mM, Sigma-Aldrich, St. Louis, MO)
Fill to 1 liter with H2O, adjust pH to 7.5 and autoclave. Dilute when needed with
autoclaved H2O in a clean, detergent-free bottle to make 1X MMR and 0.1X MMR.
modified L-15 medium (250 ml)
This recipe was adapted from Kay and Peng (1991).
2.09 g L-15 powder (Invitrogen, Grand Island, NY, catalog #41300-021)
25 ml fetal bovine serum (Fisher Scientific, Pittsburg, PA)
2.5 ml penicillin-streptomycin stock (10 000 U/ml Penicillin and 10 000 µg/ml
Streptomycin, Mediatech, Herndon, VA; catalog #30-002-CI)
Fill to 250 ml with 18 M⌦ deionized culture grade water
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Adjust pH to 7.6, filter purify using a 500 ml Nalgene vacuum filter (Thermo Scien-
tific, Waltham, MA, catalog #291-4520) in the biological hood, and store at 4 C.
10X NAM (Normal Amphibian Media) salts
This recipe is presented in Sive et al. (2000), based on the NAM formulation described
in Slack and Forman (1980).
65 g NaCl
1.5 g KCl
2.4 g Ca(NO3)2•4H2O
0.37 g Na2EDTA•2H2O
Fill to 1 liter and autoclave sterile.
1/20X NAM (1 liter)
Make sure the bottle used is detergent-free. Shake vigorously before use to introduce
O2 into solution.
5 ml 10X NAM from above
20 ml 0.1 M NaPO4 pH 7.5
500 µl 0.1 M NaHCO3 (aliquots are stored at -20 C)
Fill to 1 liter with autoclaved H2O and shake to aerate the solution.
2X NPB (Nuclear Preparation Buﬀer, 30 ml)
This recipe is from Sive et al. (2000). All reagents should be sterilized before use.
10 ml 1.5 M sucrose
0.9 ml 1 M HEPES pH 7.7
0.120 ml 0.5 M EDTA pH 8.0
3.0 mL 10 mM spermidine (Sigma-Aldrich, St. Louis, MO, catalog #S2501)
1.2 mL 10 mM spermine (Sigma-Aldrich, St. Louis, MO, catalog #S1141)
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0.608 mL 100 mM DTT
Fill to 30 mL with sterile H2O.
20% paraformaldehyde (20 ml)
In a 50 ml conical tube, add 4 g paraformaldehyde (Fisher Scientific, Pittsburg, PA)
and 20 ml DEPC H2O (see page 90). Add 2.5 µl 10N NaOH. Make sure the cap on the
conical tube is tight. Rock in a 60 C oven until solution is clear. Store at -20 C.
10X PBS (DEPC treated, 1 liter)
80 g NaCl
2 g KCl
14.4 g Na2HPO4
4.8 g KH2PO4
Fill to 1 liter with H2O, and adjust pH to 7.4. Add 1 ml DEPC in chemical hood and
vigorously shake to mix. Let vent in chemical hood overnight and autoclave.
20X PBS (1 liter)
160 g NaCl
4 g KCl
28.8 g Na2HPO4 (to make 0.2 M)
4.8 g KH2PO4 (to make 40 mM)
Fill to 1 liter with H2O, and adjust the pH so it is 7.4 when diluted 1:20. The pH of
the 20X solution may not measure at 7.4 due to extreme concentration. Autoclave. To
make 1X PBS, add 50 ml of 20X PBS to 950 ml H2O.
Ponceau S stain
0.25 g Ponceau S (Matheson, Coleman & Bell, East Rutherford, NJ)
12.5 ml glacial acetic acid
Fill to 250 ml with dH2O
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2X protein sample buﬀer (50 ml)
23.5 ml deionized water
6.25 ml 0.5 M Tris-HCl pH 6.8
12.5 ml glycerol
5 ml 20% SDS
250 µl 2% bromophenol blue (catalog # B-5525, Sigma, St. Louis, MO)
Add  -mercaptoethanol 1:20 to an aliquot immediately prior to use. Store at -20 C
once the  -mercaptoethanol is added.
PTw (500 ml, for in situ hybridization)
450 ml DEPC H2O (see page 90)
50 ml DEPC treated 10X PBS (see page 95)
500 µl Tween 20
RF1 solution (500 ml)
6 g RbCl (Sigma-Aldrich, St. Louis, MO)
5 g MnCl2•4H2O
15 ml 1 M potassium acetate
0.75 g CaCl2•2H2O
75 ml glycerol
Fill to 500 ml with H2O
Adjust pH to 5.8 with 0.2 M acetic acid.
RF2 solution (100 ml)
2 ml 0.5 M MOPS
0.12 g RbCl2
1.1 g CaCl2•2H2O
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15 ml glycerol
Fill to 100 ml with H2O
Adjust pH to 6.8 with NaOH.
1X SDB (sperm nuclei dilution buﬀer, 20 ml)
2.5 ml 2 M sucrose
750 µl 2 M KCl
20 µl 0.5 M spermidine (catalog # S2501, Sigma-Aldrich, St. Louis, MO)
8 µl 0.5 M spermine (catalog #S1141, Sigma-Aldrich, St. Louis, MO)
16.7 ml H2O
Add 20 µl 0.1 N NaOH, and confirm that the pH is between 7.3 and 7.5 using pH
paper. Filter sterile, split into 500 µl aliquots, and store at -20 C.
20X SSC (1 liter)
175.3 g NaCl
88.2 g sodium citrate
Fill to 1 liter with H2O
Adjust pH to 7.0 with HCl. Treat with DEPC in the chemical hood and autoclave.
1X TBST (1 liter)
10 ml 1 M Tris pH 7.5
20 ml 5 M NaCl
500 µL 100% Tween 20
Fill to 1 liter with H2O
1X Tris-SDS-Glycine buﬀer (1 liter)
25 ml 1 M Tris pH 9.5
14.42 g glycine
5 ml 20% SDS
Fill to 1 liter with H2O
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10X Western blot incomplete transfer buﬀer (1 liter)
30.3 g Tris base (Fisher Scientific, Pittsburg, PA)
144.2 g glycine
Dissolve in 1 liter of H2O
1X Western blot transfer buﬀer (1 liter)
100 ml 10X Western blot incomplete transfer buﬀer from above
700 ml H2O
200 ml methanol
Store at 4 C
It is important to add the H2O before adding methanol to prevent precipitate forma-
tion.
Primers
RT-PCR verification of FGF and FGFR expression
Oligonucleotides were used for assaying FGF and FGFR expression. Primer se-
quences were designed from X. laevis FGF and FGFR sequences in the NCBI database
(http://www.ncbi.nlm.nih.gov/nucleotide/) where available. For X. laevis FGFs not in
this database, primers were designed from putative genes in the JGI X. tropicalis genome
project database (http://genome.jgi-psf.org/Xentr4/Xentr4.home.html; FGFs marked
by *). All FGF primer pairs were designed to sandwich an intron sequence, aligning
the X. laevis sequences with putative JGI genomic sequences to locate introns, in order
to minimize the eﬀects of DNA contamination. In all FGFRs, the amplified region was
limited to the transmembrane domain to include both isoforms of each FGFR and to
exclude the secreted forms of FGFRs (Hanneken et al., 1994; Groth and Lardelli, 2002).
Salt adjusted melting temperature (Tm) values are noted for each primer.
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Gene Primer sequences (5’ - 3’) Tm( C)
FGF1 F TCAAGACCACAGAGACAGGG 58.8
R CAAACCAGTTCATGTCTGCG 60.3
FGF2 F AGGCTCTACTGCAAGAACGG 59.6
R TCTCCCATCTTCCTTCATGG 60.0
FGF3 F TTTAGAAATAACCGCCGTGG 58.9
R TGGAACTGTCCGATAAAGGC 59.9
FGF4 F CATCGGGTTTCATATCCAGG 60.2
R TTGATCCATACAGCTTCCCC 59.9
FGF5* F TTTCATCTCCAGATCCACCC 59.9
R GGTGTTGCATGAAGTTTCCC 60.4
FGF7 F AAACGAGGCAATGTGAAAGG 60.1
R CATTGCATGATTTCTTTCCG 59.1
FGF8 F TACACAGCATGTGAGGGAGC 59.9
R TTTCCACGATTAACTTGGCG 61.0
FGF9* F ATGGGACTATCCAAGGGACC 60.0
R CTCTTGCGTTAGCTTTTCCG 60.1
FGF10 F GCACCAAGAAGGAGAATTGC 59.8
R GACGCATAGGTGTTGTAGCC 58.3
FGF11* F TGTCACCTACTCCTCCACCC 60.0
R GCAACTTCACTGAGCTTGGG 61.0
FGF12 F TACACTGTATCGGCAGCAGG 59.9
R CCAATTTCATGCAGTGATGG 59.9
FGF13 F CGAGTGGTGGCTATTCAAGG 60.7
R GTTGAGACCCAAAAACCAGC 59.6
FGF14* F TTGTAATGGGAACCTGGTGG 60.6
R CTGCTGTCGTCCTTTGTTCC 60.8
Table 5.1 – continued on next page
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Gene Primer sequences (5’ - 3’) Tm( C)
FGF15/19* F TTGCCATTAAAGGGTATCGC 59.9
R TCCTTGCTTAGGGAGACAGC 59.6
FGF16* F GACTGTACATGGCACAAGGC 59.2
R CTGTTCAGCTTCTTCGACCC 60.0
FGF20 F TTGCTATTGGCCTGGTTAGC 60.2
R GCTACAAAGTATCGCCGTCC 59.7
FGFR1 F TTAAAATGAAGCACCCGTCG 61.0
R CGAGACTCCAGACAACATGG 59.2
FGFR2 F TCTGCATGGTAGTGGTCTGC 59.9
R GATCCTCACGAGTGGAGTGG 60.7
FGFR3 F GTGACCGAGACCAATGAAGG 60.5
R GGTGACCACAATAAGGACGG 60.2
FGFR4 F GAAGATTTCCTTGAGCAAGCC 60.3
R CAGTTTATGGACAGTTGGCG 59.2
Table 5.1 – Oligonucleotides used for RT-PCR verification of FGF and FGFR expression.
Manipulation of transgenesis construct
FGFR insertion Primers were constructed to insert dominant negative FGFR se-
quences into the CGxHG transgenesis vector adjacent to the hsp70 promoter at the 3’ end
(Figure 3.1). The forward primers contain a SacI or StuI site (double underlined below),
and the reverse primers contain an EcoRI, XbaI, or StuI site (underlined below). Reverse
primers were designed so that expression of the amplified product would be limited to the
extracellular domains and the transmembrane domain of each FGFR, eﬀectively excluding
the intracellular tyrosine kinase domains. Several bases (italicized below) were added to
the 5’ end of each primer to facilitate restriction enzyme digestion.
dnFGFR1 Forward primer: tttt gagctc atggtctccggaaggtccctc
dnFGFR1 Reverse primer: aaaaa gaattc cgggtgcttcattttaaagataatg
dnFGFR2 Forward primer: tttt aggcct atgctgctactcgcgctacttgc
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Figure 5.6 – primers for insertion into 5’ end of transgenes
Short sequences were added to the 5’ end of transgenes using primers. (A) A pair of primers
constructed the SP6 promoter sequence and 5’ untranslated region of  -globin, flanked by
AgeI and SacI restriction enzyme sites. (B) A pair of primers were used to form inserts
containing the 5’ untranslated region of  -globin, the ATG start site, and an HA tag. These
inserts were flanked by the AgeI and StuI restriction enzyme sites, or alternatively, AgeI and
SacI restriction enzyme sites.
dnFGFR2 Reverse primer: aaaa tctaga ctatggagcggtattcgtttggtgag
dnFGFR3 Forward primer: tttt gagctc atggtctctgtgaatggtgtccc
dnFGFR3 Reverse primer: aaaa aggcct ctaggggaacttggagactttatgcacc
SP6 and 5’  -globin UTR Primers were constructed to insert a SP6 promoter
sequence (double underlined below) and the 5’ untranslated region of  -globin (Krieg
and Melton, 1984; Figure 5.6A; underlined below). These sequences were flanked by
the AgeI restriction enzyme site (italicized) and SacI site. Furthermore, the restriction
sites were essentially pre-cut by not including the ends of the restriction sites, so that
the annealed pair of primers can ligate directly with a double-digested plasmid. These
primers were annealed using the thermal cycler, gradually decreasing the temperature
so that the primers would align properly while annealing. On the thermal cycler, the
SLOWCOOL program (95 C for 4 minutes, decrease 0.1 C per second until reaching 4 C,
then wait at 4 C indefinitely) was entered for this purpose. Primer sequences were verified
by sequencing after insertion into the transgenesis plasmid.
Forward primer: ccggt gatttaggtgacactatagaa
ttgttctttttgcagaagctcagaataaacgctcaactttggc gagct
Reverse primer: c gccaaagttgagcgtttattctgagcttctgcaaaaagaacaa
ttctatagtgtcacctaaatc a
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Figure 5.7 – Primer for insertion of HA tags
HA tags were inserted onto the C-terminal end of XFD (dominant negative FGFR1; Chapter
3). A pair of primers were used to form a short insert containing three copies of DNA
encoding the HA tag, flanked by EcoRI and StuI restriction enzyme sites.
5’  -globin UTR and N-terminal HA tag Two diﬀerent pairs of primers were
constructed to generate plasmids for expressing proteins with a N-terminal HA tag
(Figure 5.6B). In each case, the AgeI site is upstream (accggt; italicized below), followed
by the 5’  -globin untranslated region (underlined below), a start codon (atg), an HA tag
(encoding YPYDVPDYA; double underlined below), and then a second restriction enzyme site
(italicized and underlined below). One pair has a StuI site (aggcct) for the downstream
cut site and the the other pair of primers has a SacI site (gagctc). Each pair was then
annealed using the SLOWCOOL program as described above. The annealed primer pairs
were then double digested with their corresponding restriction enzymes, and inserted into
the transgenesis plasmid. Sequencing was used to verify proper annealing and primer
sequence.
Forward (StuI version): tagg accggt ttgttctttttgcagaagctcagaataaacgctcaactttgg
atg tacccttacgatgtacccgattatgcccatatggcc aggcct tcg
Reverse (StuI version): cga aggcct ggccatatgggcataatcgggtacatcgtaagggta cat
ccaaagttgagcgtttattctgagcttctgcaaaaagaacaa accggt ccta
Forward (SacI version): tagg accggt ttgttctttttgcagaagctcagaataaacgctcaactttgg
atg tacccttacgatgtacccgattatgcccatatggcc gagctc tcg
Reverse (SacI version): cga gagctc ggccatatgggcataatcgggtacatcgtaagggta cat
ccaaagttgagcgtttattctgagcttctgcaaaaagaacaa accggt ccta
C-terminal HA tag (3 copies) Insertion of three copies of the HA tag was accom-
plished with a pair of complementary primers (Figure 5.7). Three slightly diﬀerent codon
sequences (separated by spaces below) encoding the protein sequence YPYDVPDYA were
sandwiched between the EcoRI (underlined below) and StuI (italicized below) pre-cut
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restriction sites. The primer pair was annealed using the SLOWCOOL program prior to
ligation into the transgenesis plasmid. After ligation, the inserted primer sequence was
verified by sequencing.
Forward primer: aattc tacccttacgatgtacccgattatgcc
tacccatacgacgtcccagactacgct tatccatatgatgttccggactatgca agg
Reverse primer: cct tgcatagtccggaacatcatatggata agcgtagtctgggacgtcgtatgggta
ggcataatcgggtacatcgtaagggta g
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